EX-10.3



 Exhibit 10.3 

EXECUTION VERSION 
 BIOVENTUS
LLC 
 AMENDED AND RESTATED 

LIMITED LIABILITY COMPANY AGREEMENT 

dated as of 
 May 4, 2012 

among 
 SMITH &
NEPHEW, INC., 
 BELUGA I, INC., 

BELUGA II, INC., 

BELUGA III, INC., 

BELUGA IV, INC., 

BELUGA V, INC., 
 BELUGA
VI, INC., 
 BELUGA VII, INC., 

BELUGA VII-A, INC., 

BELUGA VIII, INC. 
 and

 BIOVENTUS LLC 







 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
		
	ARTICLE 1	  			
	DEFINITIONS	  			
			
	 Section 1.01
	 	 Definitions
	  	 	2	  
		
	ARTICLE 2	  			
	FORMATION AND PURPOSES OF THE COMPANY	  			
			
	 Section 2.01
	 	 Formation of the Company
	  	 	13	  
	 Section 2.02
	 	 Name of the Company
	  	 	13	  
	 Section 2.03
	 	 Purpose of the Company
	  	 	13	  
	 Section 2.04
	 	 Place of Business of the Company
	  	 	14	  
	 Section 2.05
	 	 Registered Office and Registered Agent
	  	 	14	  
	 Section 2.06
	 	 Term
	  	 	14	  
	 Section 2.07
	 	 Title to the Company Property
	  	 	14	  
	 Section 2.08
	 	 Filing of Certificates
	  	 	14	  
	 Section 2.09
	 	 Limitation on Liability
	  	 	14	  
		
	ARTICLE 3	  			
	CAPITAL CONTRIBUTIONS AND MEMBERSHIP UNITS	  			
			
	 Section 3.01
	 	 Units
	  	 	14	  
	 Section 3.02
	 	 Certificates
	  	 	16	  
	 Section 3.03
	 	 Additional Capital Contributions
	  	 	16	  
	 Section 3.04
	 	 Other Matters
	  	 	16	  
	 Section 3.05
	 	 Preemptive Rights
	  	 	18	  
	 Section 3.06
	 	 Agreement to be Bound
	  	 	20	  
		
	ARTICLE 4	  			
	DISTRIBUTIONS AND ALLOCATIONS	  			
			
	 Section 4.01
	 	 Distributions
	  	 	20	  
	 Section 4.02
	 	 Tax Distributions
	  	 	20	  
	 Section 4.03
	 	 Distributions in Violation of Delaware Law
	  	 	21	  
	 Section 4.04
	 	 Amounts Withheld
	  	 	21	  
	 Section 4.05
	 	 Dissolution
	  	 	21	  
	 Section 4.06
	 	 Allocations
	  	 	21	  
	 Section 4.07
	 	 Special Allocations
	  	 	22	  
	 Section 4.08
	 	 Tax Allocations
	  	 	23	  
	 Section 4.09
	 	 Reimbursement of Essex Member Administrative Expenses
	  	 	23	  
	 Section 4.10
	 	 Provisions Relating to Profits Interest Units
	  	 	24	  


  
 i 









							
		
	ARTICLE 5	  			
	THE BOARD OF MANAGERS	  			
			
	 Section 5.01
	 	 Board of Managers
	  	 	25	  
	 Section 5.02
	 	 Quorum and Manner of Acting
	  	 	25	  
	 Section 5.03
	 	 Time and Place of Meetings
	  	 	26	  
	 Section 5.04
	 	 Regular Meetings
	  	 	26	  
	 Section 5.05
	 	 Special Meetings
	  	 	26	  
	 Section 5.06
	 	 Committees
	  	 	26	  
	 Section 5.07
	 	 Subsidiaries
	  	 	26	  
	 Section 5.08
	 	 Action by Consent
	  	 	27	  
	 Section 5.09
	 	 Telephonic Meetings
	  	 	27	  
	 Section 5.10
	 	 Resignation
	  	 	27	  
	 Section 5.11
	 	 Term; Vacancies
	  	 	27	  
		
	ARTICLE 6	  			
	ACCOUNTING AND TAX MATTERS	  			
			
	 Section 6.01
	 	 Auditors and Financial Statements
	  	 	27	  
	 Section 6.02
	 	 Partnership for Tax Purposes
	  	 	28	  
	 Section 6.03
	 	 Taxable Year
	  	 	28	  
	 Section 6.04
	 	 Tax Matters Member
	  	 	28	  
		
	ARTICLE 7	  			
	INDEMNIFICATION	  			
			
	 Section 7.01
	 	 Indemnification
	  	 	31	  
	 Section 7.02
	 	 Standard of Care; Elimination of Fiduciary Duties
	  	 	32	  
	 Section 7.03
	 	 Insurance
	  	 	33	  
	 Section 7.04
	 	 Miscellaneous
	  	 	33	  
		
	ARTICLE 8	  			
	TRANSFER OF INTERESTS	  			
			
	 Section 8.01
	 	 General Restrictions
	  	 	34	  
	 Section 8.02
	 	 Transferee Rights
	  	 	35	  
	 Section 8.03
	 	 Right of First Refusal
	  	 	35	  
	 Section 8.04
	 	 Right of First Offer
	  	 	37	  
	 Section 8.05
	 	 Tag-Along Rights
	  	 	39	  
	 Section 8.06
	 	 Drag-Along Sale
	  	 	42	  
	 Section 8.07
	 	 Additional Conditions to Tag-Along Sales and Drag-Along Sales
	  	 	44	  
	 Section 8.08
	 	 Special Provisions for Member Entity Transfers
	  	 	44	  
	 Section 8.09
	 	 Essex Syndication Right
	  	 	45	  
		
	ARTICLE 9	  			
	CERTAIN COVENANTS	  			
			
	 Section 9.01
	 	 S&N Right to Veto Sale
	  	 	45	  
	 Section 9.02
	 	 OUS Subsidiary Sale
	  	 	46	  
	 Section 9.03
	 	 Company Sale Process
	  	 	46	  
	 Section 9.04
	 	 S&N Rights of First Negotiation
	  	 	47	  


  
 ii 









							
	 Section 9.05
	 	 Competitor Change of Control of S&N
	  	 	47	  
	 Section 9.06
	 	 S&N Exit Right
	  	 	48	  
	 Section 9.07
	 	 Information and Other Rights
	  	 	50	  
	 Section 9.08
	 	 Maintenance and Inspection of Records
	  	 	51	  
	 Section 9.09
	 	 Confidentiality
	  	 	51	  
	 Section 9.10
	 	 Corporate Opportunities; Non-Solicitation
	  	 	53	  
	 Section 9.11
	 	 Certain Matters Relating to an Initial Public Offering
	  	 	55	  
	 Section 9.12
	 	 Business Development Meetings
	  	 	56	  
	 Section 9.13
	 	 Essex Duties
	  	 	56	  
	 Section 9.14
	 	 Investor Duties
	  	 	56	  
	 Section 9.15
	 	 Orthobiologics Commitment
	  	 	56	  
	 Section 9.16
	 	 Compliance with Applicable Law
	  	 	57	  
	 Section 9.17
	 	 Certain Members’ Assets and Liabilities
	  	 	57	  
	 Section 9.18
	 	 S&N Accounting Periods
	  	 	57	  
	 Section 9.19
	 	 Remedies Upon Breach
	  	 	57	  
		
	ARTICLE 10	  			
	TERM, DISSOLUTION AND LIQUIDATION	  			
			
	 Section 10.01
	 	 Term
	  	 	58	  
	 Section 10.02
	 	 Liquidating Events
	  	 	58	  
	 Section 10.03
	 	 Winding Up
	  	 	58	  
	 Section 10.04
	 	 Distribution Upon Dissolution of the Company
	  	 	58	  
	 Section 10.05
	 	 Liquidation or Dissolution
	  	 	59	  
	 Section 10.06
	 	 Company Sale
	  	 	61	  
	 Section 10.07
	 	 Rights of Members; Resignation
	  	 	61	  
		
	ARTICLE 11	  			
	MISCELLANEOUS	  			
			
	 Section 11.01
	 	 Notices
	  	 	62	  
	 Section 11.02
	 	 Representations and Warranties
	  	 	63	  
	 Section 11.03
	 	 Amendments; No Waivers
	  	 	63	  
	 Section 11.04
	 	 Expenses
	  	 	64	  
	 Section 11.05
	 	 Public Announcements
	  	 	64	  
	 Section 11.06
	 	 Successors and Assigns
	  	 	64	  
	 Section 11.07
	 	 Headings
	  	 	64	  
	 Section 11.08
	 	 Governing Law
	  	 	64	  
	 Section 11.09
	 	 Jurisdiction
	  	 	64	  
	 Section 11.10
	 	 WAIVER OF JURY TRIAL
	  	 	65	  
	 Section 11.11
	 	 Entire Agreement
	  	 	65	  
	 Section 11.12
	 	 Counterparts; Effectiveness
	  	 	65	  
	 Section 11.13
	 	 Severability
	  	 	65	  
	 Section 11.14
	 	 Further Assurances
	  	 	65	  
	 Section 11.15
	 	 Specific Performance
	  	 	65	  

  

			
	Schedule I	  	Capital Contributions and Units


  
 iii 









			
	Annex A	  	Certain Approval Rights
	Annex B	  	Registration Rights
	Annex C	  	Terms ofPreferred Units and Converted Common Units
	Annex D	  	Orthobiologics Commitment
	Annex E	  	Allocation for Assets Contributed Per S&N-Company Contribution Agreement
	Annex F	  	Allocation for Assets Contributed per Essex-Company Contribution Agreement
	Annex G	  	Terms of EPR Unit


  
 iv 








 AMENDED AND RESTATED 

LIMITED LIABILITY COMPANY AGREEMENT 

OF 
 BIOVENTUS LLC

 THIS AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT (this “Agreement”) of Bioventus LLC (the
“Company”) is dated as of May 4, 2012 among the Company, Smith & Nephew, Inc., a Delaware corporation (“S&N”), Beluga I, Inc., a Delaware corporation (“Beluga I”), Beluga II, Inc.,
a Delaware corporation (“Beluga II”), Beluga III, Inc., a Delaware corporation (“Beluga III”), Beluga IV, Inc., a Delaware corporation (“Beluga IV”), Beluga V, Inc., a Delaware corporation
(“Beluga V”), Beluga VI, Inc., a Delaware corporation (“Beluga VI”), Beluga VII, Inc., a Delaware corporation (“Beluga VII”), Beluga VII-A, Inc., a Delaware corporation (“Beluga
VII-A”), Beluga VIII, Inc., a Delaware corporation (“Beluga VIII”), Mark A. Augusti and each other Member listed on the signature pages hereto from time to time. 

WITNESSETH: 

WHEREAS, the Company was formed as a limited liability company pursuant to Delaware Law by filing a Certificate of Formation with the
Office of the Secretary of State of the State of Delaware on November 23, 2011, and S&N, as the sole initial member, entered into a Limited Liability Company Agreement of the Company (the “Initial LLC Agreement”) dated
November 29, 2011; 
 WHEREAS, on the date hereof, pursuant to transactions consummated in accordance with (i) the
Purchase Agreement (as amended from time to time, the “Purchase Agreement”) dated as of January 3, 2012 among S&N, Smith & Nephew plc (“S&N plc”) and the Essex Members, (ii) the
Contribution Agreement (as amended from time to time, the “S&N-Company Contribution Agreement”) dated as of January 3, 2012 among S&N, S&N plc, the Essex Members and the Company and (iii) the Contribution
Agreement (as amended from time to time, the “Essex-Company Contribution Agreement”, and together with the S&N-Company Contribution Agreement, the “U.S. Contribution Agreements”) dated as of January 3, 2012
among the Essex Members and the Company, the Company has issued Preferred Units to each Essex Member and Common Units and an EPR Unit to S&N, in each case in the amounts set forth on Schedule I hereto; 

WHEREAS, immediately following the closing of the transactions contemplated by the U.S. Contribution Agreements, the Essex Members shall hold
4,659,153 Preferred Units in the aggregate and S&N shall hold 4,476,440 Common Units and one EPR Unit; 
 WHEREAS, on the date hereof,
the Profits Interest Members shall be issued 288,889 Profits Interest Units in the aggregate pursuant to the Management Incentive Plan and certain Award Agreements (in each case, as defined below) between the Company and such Profits Interest
Members; 

  
 1 








 WHEREAS, the parties hereto wish to enter into this Agreement, effective immediately following
the consummation of the transactions contemplated by the Essex-Company Contribution Agreement, to, among other things, (i) amend and restate the Initial LLC Agreement in its entirety and to memorialize the recapitalization of the Company,
(ii) admit the Essex Members and the Profits Interest Members as Members, (iii) provide for the management of the Company and (iv) set forth the respective rights and obligations of Members of the Company generally; 

WHEREAS, on June 1, 2012, pursuant to transactions consummated in accordance with the OUS Contribution and Purchase Agreement (the
“OUS Contribution Agreement”) dated as of January 3, 2012 among S&N plc, the Essex Members and the Company, the Company will issue 440,847 Preferred Units in the aggregate to the Essex Members and 423,560 OUS Units to
Smith & Nephew OUS, Inc., a Delaware corporation (“S&N Blocker”) and/or to S&N; 
 WHEREAS,
immediately following the Initial OUS Closing (as defined in the OUS Contribution Agreement), the Essex Members shall hold 5,100,000 Preferred Units in the aggregate and S&N and S&N Blocker shall hold 4,900,000 Common Units and OUS Units in
the aggregate (in each case, assuming that no Units have been Transferred by, or otherwise issued to, any such Person prior to the Initial OUS Closing); and 

WHEREAS, the parties hereto intend that the rights of the OUS Units hereunder will include a claim on the OUS Gain, on the terms and subject
to the conditions set forth in this Agreement. 
 NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set
forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 

ARTICLE 1 
 DEFINITIONS 

Section 1.01 Definitions. (a) As used herein, the following terms have the following meanings: 

“Affiliate” means, with respect to any Person, any other Person directly or indirectly controlling, controlled by, or
under common control with such other Person. For purposes of this definition, (i) “control” when used with respect to any Person means the power to direct the management and policies of such Person, directly or indirectly, whether
through the ownership of voting securities, by contract or otherwise, and the terms “controlling” and “controlled” have correlative meanings, and (ii) no Member or any of its Affiliates shall by reason of this Agreement or
the Related Documents be deemed to be an Affiliate of any other Member or of the Company. 
 “Applicable Class
Percentage” means, as of any applicable time, with respect to any Class of Profits Interest Units, (i) the Outstanding Number of Profits Interest Units of such Class of Profits Interest Units divided by (ii) the total number of
Units then outstanding, excluding the EPR Unit. 

  
 2 








 “Applicable Law” means, with respect to any Person, any transnational,
domestic or foreign federal, provincial, state or local law (statutory, common or otherwise), constitution, directive, treaty, convention, ordinance, code, rule, regulation, order, injunction, judgment, decree, ruling, writ, stipulation,
determination, award or other similar requirement enacted, adopted, promulgated, applied or entered by a Governmental Authority that is binding upon or applicable to such Person, as amended unless expressly specified otherwise. 

“Assumed Tax Rate” means 40%, or such higher rate as may from time to time be determined by the Board of Managers.

 “Award Agreement” means a grant, purchase or other agreement between the Company and a Profits Interest
Member pursuant to which the Company has issued Profits Interest Units to such Profits Interest Member or between the Company and any grantee under the Phantom Profits Interest Units Plan pursuant to which the Company has issued Phantom Profits
Interest Units to such grantee. 
 “Benchmark Amount” means, with respect to any Class of Profits Interest
Units, the cumulative distributions that must be made by the Company to the Members pursuant to Section 4.01 (other than Preferred Distributions and Accrued Preferred Distributions and, for the avoidance of doubt, any Tax Distribution (or
distribution treated as a Tax Distribution) made pursuant to Section 4.02) and Sections 10.05(a)(ii) through (v) before a Profits Interest Member is entitled to receive any distributions in respect of the Profits Interest Units of such
Class of Profits Interest Units. 
 “Book Value” means, with respect to any property of the Company, the
Company’s adjusted basis in such property for federal income tax purposes, provided that (i) the initial Book Value of any property contributed to the Company shall the gross fair market value of such asset on the date of the contribution,
and (ii) Book Value shall be adjusted from time to time to reflect the adjustments required or permitted by Treasury Regulations Section 1.704- 1(b)(2)(iv)(e)-(g). 

“Business Day” means a day, other than Saturday, Sunday or other day on which commercial banks in New York, New York
or London, England are authorized or required by Applicable Law to close. 
 “Capital Account” means the
separate account established by the Company for each Member according to the rules of Treasury Regulation Section 1.704-1(b)(2)(iv). For this purpose, the Company may (in the discretion of the Board of Managers), upon the occurrence of the
events specified in Treasury Regulation Section 1.704-1(b)(2)(iv)(f), increase or decrease the Capital Accounts in accordance with the rules of such regulation and Treasury Regulation Section 1.704-1(b)(2)(iv)(g) to reflect a revaluation
of Company property. 
 “Capital Contribution” means any cash, third party promissory obligations (valued at
the fair market value thereof) or other property (valued at the fair market value thereof) which a Member contributes to the Company. The Capital Contribution of each of the Members for their Units is set forth on Schedule I attached hereto, as the
same may be amended from time to time in accordance with the requirements of this Agreement. Each Member (other than the Investors) acknowledges and agrees that Schedule I may be redacted or information thereon may otherwise be aggregated to
prevent disclosure of confidential information as the Board of Managers may determine from time to time. 

  
 3 








 “Certificate of Formation” means the Certificate of Formation of the
Company filed with the office of the Secretary of State of the State of Delaware, as it may be amended from time to time. 

“Class Entitlement per Unit” means, as of any applicable time, with respect to any Class of Profits Interest Units, an
amount equal to (i) the Applicable Class Percentage of such Class of Profits Interest Units multiplied by (ii) the excess, if any, of (A) the Amount Available for Distribution over (B) the sum of the Benchmark Amount applicable
to such Class of Profits Interest Units and the amount of the EPR Entitlement, if any, divided by (iii) the Outstanding Number of Profits Interest Units of such Class of Profits Interest Units. 

“Class of Profits Interest Units” means, collectively, any and all Profits Interest Units having the same Benchmark
Amount (regardless of whether granted or issued pursuant to separate grants or issuances). 
 “Clinical Therapies
Field” means (i) bone growth stimulation of the type addressed by the Exogen product, (ii) joint fluid therapy of the type addressed by the Supartz and Durolane products and (iii) the products addressed by the ScoliScore
co-marketing arrangement and the GE Ultrasound distribution agreement/pilot, in each case as conducted through S&N’s Biologics and Clinical Therapies Global Business Unit. 

“Code” means the Internal Revenue Code of 1986, as amended from time to time. 

“Common Unit” means a Unit representing a fractional part of the Members’ ownership interests in the Company and
having the rights and obligations specified with respect to Common Units in this Agreement. 
 “Company
Securities” means (i) any Units or other equity or equity-linked securities of the Company, (ii) any securities convertible into or exchangeable for Units or other equity or equity-linked securities of the Company and
(iii) any options, warrants or other rights to acquire Units or other equity or equity-linked securities of the Company. 

“Damages” has the meaning assigned to such term in the S&N-Company Contribution Agreement. 

“EPR Unit” means the Unit issued in partial consideration for the Capital Contribution of S&N made pursuant to the
S&N-Company Contribution Agreement representing the right to receive the EPR Entitlement, if any, as provided in Section 10.05(a)(iv) and Annex G, and having the other rights set forth on Annex G. 

“Essex” means Essex Woodlands Health Ventures VIII, L.P., a Delaware limited partnership. 

“Essex Commitment Letter” means the letter agreement dated as of January 3, 2012 among S&N plc, S&N and
Essex Fund VIII. 

  
 4 








 “Essex Fund VIII” means Essex Woodlands Health Ventures Fund VIII, L.P.,
a Delaware limited partnership. 
 “Essex Funds” means, collectively, (i) Essex Fund VIII,
(ii) Essex Woodlands Health Ventures Fund VIII-A, L.P., a Delaware limited partnership, (iii) Essex Woodlands Health Ventures Fund VIII-B, L.P., a Delaware limited partnership and (iv) White Pine Medical LLC. 

“Essex GP” means Essex Woodlands Health Ventures VIII, LLC, the general partner of Essex. 

“Essex Investors” means each of the Essex Funds, Spindletop Healthcare Capital, L.P., Pantheon Global Co-Investment
Opportunities Fund, L.P. (“Pantheon”), Ampersand 2006 Limited Partnership, Ampersand 2011 Limited Partnership and Alta Partners VIII, LP.  

“Essex Member” means each of Beluga I, Beluga II, Beluga III, Beluga IV, Beluga V, Beluga VI, Beluga VII, Beluga VII-A
and Beluga VIII, for so long as such Person is a Member and is controlled by Essex or Essex GP. For purposes of this definition, “controlled” has the meanings assigned to such terms in the definition of “Affiliate”
herein. 
 “Exit” means the first to occur of (i) consummation of a Company Sale or
(ii) consummation of a Qualified Initial Public Offering. 
 “Expense Side Letter” means the letter
agreement dated as of January 3, 2012 among S&N, Essex and the Company. 
 “Fair Market Value” means
the fair market value of the Company and its Subsidiaries, as determined using commonly accepted valuation techniques where applicable, based upon the aggregate amount that would be recovered by the holders of the Company Securities if all of the
Company Securities were sold to a buyer in a single transaction and the proceeds from such transaction were allocated to the holders of the Company Securities as if the proceeds were distributed in a liquidation or dissolution of the Company
pursuant to Article 10 hereof or, as applicable, the fair market value of the OUS Subsidiary and its Subsidiaries, as determined using commonly accepted valuation techniques where applicable, based upon the aggregate amount that would be recovered
by the Company if the OUS Subsidiary were sold to a buyer in a single transaction. 
 “Family Group” means a
Member’s spouse and descendants (whether by birth or adoption) and any trust solely for the benefit of such Member and/or such Member’s spouse and/or such Member’s descendants (by birth or adoption), parents or dependents, or any
charitable trust the grantor of which is such Member and/or one or more members of the Member’s Family Group. 

“Fiscal Year” means the annual period ending on December 31 of each year, or as otherwise determined by the Board
of Managers in accordance with the provisions of this Agreement. 
 “GAAP” means generally accepted
accounting principles in the United States. 

  
 5 








 “Governmental Authority” means any transnational, domestic or foreign
federal, provincial, state or local governmental, regulatory or administrative authority (including the Centers for Medicare & Medicaid Services), department, court, agency or official, including any political subdivision thereof.

 “IFRS” means the International Financial Reporting Standards as issued by the International Accounting
Standards Board and as adopted by the European Union. 
 “Indebtedness” of any Person means, without
duplication: (i) all obligations of such Person for borrowed money, (ii) all obligations of such Person evidenced by bonds, debentures, notes or other similar instruments (other than performance, surety and similar bonds or instruments),
(iii) all obligations of such Person to pay the deferred purchase price of property or services, except trade accounts payable and accrued expenses arising in the ordinary course of business, (iv) all obligations of such Person as lessee
under any leases which are required to be capitalized in accordance with GAAP, (v) all obligations of others of the type described above secured by a Lien on any asset of such Person whether or not such obligation is assumed by such Person and
(vi) all obligations of others of the type described above guaranteed by such Person. 
 “Initial Public
Offering” means the initial Public Offering. 
 “Investor” means each of (i) S&N and its
Permitted Transferees and (ii) each of the Essex Members and its Permitted Transferees. 
 “License
Agreement” means the License Agreement dated as of the date hereof between S&N and the Company. 

“Lien” means, with respect to any property or asset, any mortgage, lien, pledge, charge, security interest or
encumbrance in respect of such property or asset. 
 “Management Incentive Plan” means the Bioventus LLC
Management Incentive Plan effective as of the date hereof. 
 “Member” means each Person that executed this
Agreement as a member on the signature pages hereto and any other Person who may from time to time be admitted to the Company as an additional or substitute member as provided herein, in each case in such Person’s capacity as a member of the
Company. 
 “Member Entity Transfer” means, in the case of any Investor, a direct or indirect sale,
assignment, disposition, exchange, pledge, encumbrance, hypothecation or other transfer by its shareholders, partners or members of the equity interests of such Member or any participation or interest therein or any agreement or commitment to do any
of the foregoing. 
 “Orthobiologics Field” means Active Therapies targeted at Orthopedic Applications, as
conducted through S&N’s Biologics and Clinical Therapies Global Business Unit, but excludes the Clinical Therapies Field. As used herein, “Active Therapies” means cell-based therapies, small molecules, growth factors, gene
therapy, and other novel biologically-active materials such as peptides and statins or inert products that, when combined in an active matrix or delivery substrate, promote bone healing, cartilage regeneration and/or soft tissue healing. 


  
 6 








 “Orthopedic Applications” mean any of the following: total or partial
joint arthroplasty, orthopedic arthroscopic procedures commonly referred to as sports medicine procedures, spinal procedures and other procedures related to orthopedic specialty areas. 

“OUS Gain” means, at the time of any transaction giving rise to distributions pursuant to Section 10.05(a), an
amount equal to the lower of (i) the excess, if any, of (A) the Fair Market Value of the OUS Subsidiary and its Subsidiaries, if any, as reasonably determined by S&N, over (B) $20,000,000 and (ii) the total amount available
for distribution pursuant to Sections 10.05(a)(v)(B) through (D). 
 “OUS Subsidiary” means the Subsidiary of
the Company that will purchase the OUS Assets and assume the OUS Assumed Liabilities (as each such term is defined in the OUS Contribution Agreement) pursuant to the OUS Contribution Agreement. 

“OUS Unit” means a Unit representing a fractional part of the Members’ ownership interests in the Company and
having the rights and obligations specified with respect to OUS Units in this Agreement. 
 “Outstanding Common
Percentage” means, as of any applicable time, (i) the total number of Common Units then outstanding divided by (ii) the sum of (A) the total number of Common Units then outstanding and (B) the total number of OUS Units
then outstanding. 
 “Outstanding Number of Profits Interest Units” means, with respect to any Class of
Profits Interest Units, the total number of Profits Interest Units of such Class of Profits Interest Units then outstanding. 

“Outstanding OUS Percentage” means, as of any applicable time, (i) the total number of OUS Units then outstanding
divided by (ii) the sum of (A) the total number of Common Units then outstanding and (B) the total number of OUS Units then outstanding. 

“Percentage Interest” means, with respect to each Investor, at any time, a fraction representing the ownership
percentage of the Company, the numerator of which is the number of Units held by such Investor, and the denominator of which is the aggregate number of Units held by all Investors. For the avoidance of doubt, (i) as of the closing of the
transactions contemplated by the U.S. Contribution Agreements, the aggregate Percentage Interest of the Essex Members is 51% and the Percentage Interest of S&N is 49% and (ii) each Investor’s Percentage Interest shall be determined
without regard to the EPR Unit. 
 “Permitted Transferee” means, (i) with respect to any Investor, any
Affiliate of such Investor for so long as such Affiliate remains an Affiliate of such Investor or (ii) with respect to any Member that is a natural person, any Transferee pursuant to the applicable laws of descent or distribution or among a
Member’s Family Group. For the avoidance of doubt, S&N Blocker shall be deemed to be a Permitted Transferee for all purposes under this Agreement. Notwithstanding anything to the contrary set forth herein, a Transferee that is an entity
shall be a Permitted Transferee of a Member only if such Transferee is an entity that is organized under the laws of a jurisdiction within the United States. 

  
 7 








 “Person” means an individual, corporation, partnership, limited liability
company, association, trust or other entity or organization, including a Governmental Authority. 
 “Phantom Profits
Interests Plan” means the Bioventus LLC Phantom Profits Interests Plan effective as of the date hereof. 

“Phantom Profits Interest Unit” means an award under the Phantom Profits Interests Plan. 

“Preferred Unit” means a Unit representing a fractional part of the Members’ ownership interests in the Company
and having the rights and obligations specified with respect to Preferred Units in this Agreement. 
 “Profits
Interest Member” means a Member that holds Profits Interest Units (in such Member’s capacity as a holder thereof). 

“Public Offering” means an underwritten public offering of equity securities of the Company or any of its Subsidiaries
pursuant to an effective registration statement under the Securities Act, other than pursuant to a registration statement on Form S-4 or Form S-8 or any similar or successor form. 

“Qualified Initial Public Offering” means an Initial Public Offering on a leading national exchange which yields net
proceeds to the Company (excluding amounts, if any, used to repay the S&N Note and after the payment of investment banking fees, underwriting discounts, commissions, costs and other reasonable out-of-pocket expenses and other customary expenses
incurred by the Company in connection with such Initial Public Offering) of at least $60,000,000 and which results in an aggregate equity valuation of the Company of at least $400,000,000. 

“Related Documents” means the S&N-Company Contribution Agreement, the Purchase Agreement, the Essex-Company
Contribution Agreement, the OUS Contribution Agreement, the License Agreement, the Transition Services Agreement, the Reverse Transition Services Agreement, the Essex Commitment Letter and the Expense Side Letter. 

“Return Preparer” means the “Income Tax Return Preparer” for the Company as defined in
Section 7701(a)(36) of the Code, not taking into account Section 7701(a)(36)(B), which at all times shall be a nationally recognized accounting firm. 

“Reverse Transition Services Agreement” means the Reverse Transition Services Agreement dated as of the date hereof
among S&N plc, S&N and the Company. 
 “ROFO Percentage” means, with respect to any Investor other
than the Transferring Member and for any Transfer subject to Section 8.04, a fraction the numerator of which is the number of Units owned, directly or indirectly, by such Investor immediately prior to such Transfer and the denominator of which
is the number of Units owned, directly or indirectly, by all Investors other than the Offering Member immediately prior to such Transfer. For the avoidance of doubt, an Investor’s ROFO Percentage shall be determined without regard to the EPR
Unit. 

  
 8 








 “ROFR Percentage” means, with respect to any Investor other than the
Offering Member and for any Transfer subject to Section 8.03, a fraction the numerator of which is the number of Units owned, directly or indirectly, by such Investor immediately prior to such Transfer and the denominator of which is the number
of Units owned, directly or indirectly, by all Investors other than the Offering Member immediately prior to such Transfer. For the avoidance of doubt, an Investor’s ROFR Percentage shall be determined without regard to the EPR Unit.

 “S&N Accounting Month” means the monthly accounting period of S&N and its Affiliates as in effect
from time to time, as provided to the Company pursuant to Section 9.18. 
 “S&N Accounting Quarter” means
the quarterly accounting period of S&N and its Affiliates as in effect from time to time, as provided to the Company pursuant to Section 9.18. 

“S&N Note” means the senior secured note between S&N, as borrower, and Smith & Nephew Holdings, Inc.,
as lender, in aggregate principal amount of $160,000,000, which note was assumed by the Company pursuant to the S&N¬Company Contribution Agreement. To the extent the S&N note is assigned or transferred in part from time to time in
accordance with the terms thereof, all references herein to the “S&N Note” shall be deemed to refer to all notes created by or issued in connection with such transfers or assignments, collectively. 

“Securities Act” means the Securities Act of 1933, as amended.  

“Service” means the Internal Revenue Service. 

“Specified Asset Sale” means any sale, transfer, issuance, conveyance, assignment or other disposition of any
Collateral (as defined in the S&N Note) (other than in the ordinary course of business) in each case with a value of more than $1,500,000 in the aggregate in any Fiscal Year from all such sales, transfers, issuances, conveyances, assignments or
other dispositions. 
 “Subsidiary” of any Person means any entity of which securities or other ownership
interests having ordinary voting power to elect a majority of the board of directors or other persons performing similar functions are at the time directly or indirectly owned by such Person. 

“Tag-Along Percentage” means, for any Tag-Along Sale, a fraction the numerator of which is the number of Units
proposed to be Transferred by the Essex Offering Member in such Tag-Along Sale and the denominator of which is the aggregate number of Units owned, directly or indirectly, by the Essex Offering Member immediately prior to such Tag-Along Sale.

 “Tag-Along Portion” means, with respect to any Member other than the Essex Offering Member and for any
Tag-Along Sale, (i) the number of Units (excluding, for the avoidance of doubt, the EPR Unit) owned, directly or indirectly, by such Member immediately prior to such Tag-Along Sale multiplied by (ii) the Tag-Along Percentage. 

“Tax Matters Member” means the Member designated as such pursuant to Section 6.04. 

  
 9 








 “Transfer” means, with respect to any Units, (i) when used as a
verb, to sell, assign, dispose of, exchange, pledge, encumber, hypothecate or otherwise transfer such Units or any participation or interest therein, whether directly or indirectly, or agree or commit to do any of the foregoing and (ii) when
used as a noun, a direct or indirect sale, assignment, disposition, exchange, pledge, encumbrance, hypothecation, or other transfer of such Units or any participation or interest therein or any agreement or commitment to do any of the foregoing;
“Transferee” means a person to whom a Transfer is made or is proposed to be made; and “Transferor” means a person that Transfers or proposes to Transfer. For the avoidance of doubt, the term
“Transfer” includes (i) a direct or indirect sale, assignment, disposition, exchange, pledge, encumbrance, hypothecation or other transfer however structured (whether pursuant to merger, consolidation, business combination or
other similar transaction or by operation of law) and (ii) any Member Entity Transfer. 
 “Transition Services
Agreement” means the Transition Services Agreement dated as of the date hereof among S&N plc, S&N and the Company. Any reference herein to a particular provision of the Treasury Regulations means, where appropriate, the
corresponding successor provision. 
 “Treasury Regulations” means the Treasury regulations promulgated under
the Code, as such Treasury Regulations may be amended from time to time. 
 “Unreturned Capital Amount”
means, with respect to each Common Unit or OUS Unit, an amount equal to the excess, if any, of (i) the aggregate amount of Capital Contributions made in exchange for or on account of such Common Unit or OUS Unit (including all such amounts set
forth on Schedule I), over (ii) the aggregate amount of prior distributions made by the Company on account of such Common Unit or OUS Unit pursuant to Section 4.01. 

“U.S. Gain” means, at the time of any transaction giving rise to distributions pursuant to Section 10.05(a), the
difference between (i) the total amount available for distribution pursuant to Sections 10.05(a)(v)(B) through (D) minus (ii) the OUS Gain. 

(b) Each of the following terms is defined in the Section set forth opposite such term: 

 

			
	Term	  	Section
	Accrued Preferred Distribution	  	Annex C
	Active Therapies	  	1.01(a)
	Agreement	  	Preamble
	Amount Available for Distribution	  	Annex G
	Adjusted Common/OUS Percentage	  	Annex G
	Applicable Common/OUS Percentage	  	Annex G
	Applicable EPR Percentage	  	Annex G
	Automatic Conversion	  	9 .11 (b)
	Beluga I	  	Preamble
	Beluga II	  	Preamble
	Beluga III	  	Preamble
	Beluga IV	  	Preamble
	Beluga V	  	Preamble


  
 10 









			
	Term	  	Section
	Beluga VI	  	Preamble
	Beluga VII	  	Preamble
	Beluga VII-A	  	Preamble
	Beluga VIII	  	Preamble
	Board of Managers	  	5.01(a)
	Breaching Investor	  	9.19
	Business Development Committee	  	9.12
	Certificate	  	3.02
	Chairman	  	5.01(a)(iv)
	Common/OUS Percentage	  	Annex G
	Company	  	Preamble
	Company Party	  	7.01
	Company Sale	  	9.01(a)
	Competitor	  	9 .01(b)
	Competitor Change of Control of S&N	  	9.05
	Competitor Sale	  	9.01(b)
	Confidential Information	  	9.09(a)
	Converted Common Unit	  	Annex C
	Core Competencies	  	Annex D
	Corporate Conversion	  	9.11(a)
	Deciding Member	  	8.03(a)
	Delaware Law	  	2.01
	Drag-Along Sale	  	8.06(a)
	Drag-Along Sale Notice	  	8.06(b)
	Drag-Along Sale Price	  	8.06(b)
	Drag-Along Transferee	  	8.06(a)
	Electing Members	  	8.04(a)
	e-mail	  	11.01
	EPR Entitlement	  	Annex G
	Essex-Company Contribution Agreement	  	Recitals
	Essex Offering Members	  	8.05(a)
	Essex Purchase	  	9.06(b)(iii)
	Essex Purchase Option	  	9.06(b)(iii)
	Essex Purchase Option Period	  	9.06(b)(iii)
	Essex Units	  	8.06(a)
	Exchange Act	  	5.01(b)
	FDA	  	9.16(b)
	Financial Advisor	  	9.06(a)
	First EPR Event	  	Annex G
	First Post-IPO EPR Event	  	Annex G
	Fund	  	9.09(d)
	Fund Manager	  	9.09(d)
	Indemnified Service	  	7.01
	Independent	  	5.01(b)
	Initial Liquidation Preference	  	Annex C


  
 11 









			
	Term	  	Section
	Initial LLC Agreement	  	Recitals
	Initiating Members	  	8.06(a)
	IPO Entity	  	9.11(a)
	IPO Percentage	  	9.11(b)
	IRS Notice	  	4.10(b)
	Issuance Notice	  	3.05(a)
	Liquidating Event	  	10.02
	Liquidation Preference	  	Annex C
	Management Incentive Plan	  	3.01(b)
	Manager	  	5.01(a)
	Member Entity ROFR Price	  	8.03(a)
	Member Entity ROFO Price	  	8.04(b)
	Member Unit ROFO Price	  	8.04(e)
	Member Unit ROFR Price	  	8.03(e)
	New Product Partnership	  	9.04(b)
	Non-Breaching Investor	  	9.19
	Orthobiologics Commitment	  	Annex D
	Offer	  	8.04(b)
	Offer Notice	  	8.03(a)
	Offering Member	  	8.03(a)
	Other Business	  	9.10(b)
	Other Management Equity Awards	  	3.01(b)(iii)
	Other Management Equity Plan	  	Annex A
	Other Members	  	8.06(a)
	OUS Contribution Agreement	  	Recitals
	OUS Subsidiary Sale	  	9.02
	Pantheon	  	1.01(a)
	Pantheon Fund	  	9.09(d)
	Parent	  	Preamble
	Percentage Milestone	  	Annex G
	PIM Tag-Along Trigger Event	  	8.05(a)
	Preferred Distribution	  	Annex C
	Preferred Percentage	  	Annex G
	Preferred Transfer Event	  	Annex C
	Proceeding	  	7.01
	Profits Interest Unit	  	3.01(b)
	Purchase Agreement	  	Recitals
	Recommended Exit	  	9.06(b)(i)
	Recommended Exit Notice	  	9.06(b)(i)
	Recommended Exit Veto Period	  	9.06(b)(ii)
	Regulatory Allocations	  	4.07(b)
	Remaining Securities	  	3.05(b)
	Replacement EPR Security	  	Annex G
	ROFO Notice	  	8.04(a)
	ROFO Period	  	8.04(b)


  
 12 









			
	Term	  	Section
	ROFO Response Notice	  	8.04(b)
	ROFO Termination	  	8.04(d)
	ROFR Period	  	8.03(b)
	ROFR Right to Purchase	  	8 .03(b)
	ROFR Termination	  	8.03(d)
	S&N	  	Preamble
	S&N Acquisition	  	9.04(a)
	S&N Blocker	  	Recitals
	S&N-Company Contribution Agreement	  	Recitals
	S&N plc	  	Recitals
	Safe Harbor Election	  	4.10(b)
	Similar Confidentiality Obligations	  	9.09(d)
	Tag-Along Notice	  	8.05(a)
	Tag-Along Response Notice	  	8.05(b)
	Tag-Along Right	  	8.05(b)
	Tag-Along Right Period	  	8.05(b)
	Tag-Along Sale	  	8.05(a)
	Tagging Member	  	8.05(b)
	Tax Distribution	  	4.02(a)
	Transfer Conversion	  	Annex C
	Transferring Member	  	8.04(a)
	Units	  	3.01(a)
	U.S. Contribution Agreements	  	Recitals
	Veto	  	9.06(b)(ii)
	Veto Party	  	9.06(b)(v)

 ARTICLE 2 

FORMATION AND PURPOSES OF THE COMPANY 

Section 2.01 Formation of the Company. The Company has previously been formed pursuant to the Delaware
Limited Liability Company Act, 6 Del. Code § 18-101 et seq. (as amended, and any successor to such statute, “Delaware Law”). The rights and liabilities of the Members shall be as provided for in Delaware Law if not otherwise
expressly modified or provided for in this Agreement. 
 Section 2.02 Name of the Company. The name
of the Company shall be “Bioventus LLC” or such other name as the Board of Managers shall approve. 

Section 2.03 Purpose of the Company. The purpose of the Company is to engage in any lawful act or activity for which limited
liability companies may be formed under the Delaware Law and in any and all activities necessary or incidental to the foregoing. In furtherance of its purpose, the Company shall have and may exercise all the powers now or hereafter conferred by
Delaware Law on limited liability companies. The Company shall have the power to do any and all acts necessary, appropriate, proper, advisable, incidental or convenient to or for the protection and benefit of the Company, and shall have, without


  
 13 








 
limitation, any and all of the powers that may be exercised on behalf of the Company by the Members, it being understood that (i) the operation of the Company is subject to the provisions of
this Agreement and (ii) no Member shall be entitled to bind the Company, except as contemplated by this Agreement or as established by the Board of Managers in the manner contemplated hereby. 

Section 2.04 Place of Business of the Company. The principal place of business of the Company shall be located at such place as
shall be determined from time to time by the Board of Managers. The Company shall also have such additional offices as shall be determined from time to time by the Board of Managers. 

Section 2.05 Registered Office and Registered Agent. The address of the registered office of the Company in the State of Delaware
is c/o Corporation Trust Center, 1209 Orange Street, City of Wilmington, County of New Castle, Delaware 19801. The name of the registered agent for service of process on the Company at such address is The Corporation Trust Company. 

Section 2.06 Term. The Company commenced on the date of the filing of the Certificate of Formation, and the term of the Company
shall continue until the dissolution of the Company in accordance with the provisions of Article 10 hereof or as otherwise provided by law. 

Section 2.07 Title to the Company Property. All property of the Company and its Subsidiaries, whether real or personal, tangible
or intangible, shall be deemed to be owned by the Company or its Subsidiaries, as the case may be, as an entity, and no Member, individually, shall have any direct ownership interest in such property. 

Section 2.08 Filing of Certificates. The officers of the Company shall file and publish all such certificates, notices, statements
or other instruments required by law (a) to evidence the formation of the Company and (b) for the operation of the Company in all jurisdictions where the Company may elect from time to time to do business. 

Section 2.09 Limitation on Liability. Except as required by Delaware Law, the debts, obligations and liabilities of the Company,
whether arising in contract, tort or otherwise, shall be solely the debts, obligations and liabilities of the Company, and no Member shall be obligated for any such debt, obligation or liability of the Company solely by reason of being a Member.
Other than with respect to the Essex Members (vis-à-vis each other), the Members shall not act as agents for one another or incur debts, obligations or liabilities on behalf of other Members. 

ARTICLE 3 
 CAPITAL CONTRIBUTIONS
AND MEMBERSHIP UNITS 
 Section 3.01 Units. (a) The Members’ ownership interests in the Company shall be
represented by units having the rights and obligations specified in this Agreement with respect to Preferred Units, Common Units, the OUS Units, the EPR Unit and the Profits Interest Units (collectively, the “Units”). Subject to
Sections 3.01(b) and 5.02(b), the Company shall have the authority to issue an unlimited number of Units, of which 4,659,153 Preferred Units, 4,476,440 Common Units, one EPR Unit and 288,889 Profits Interest Units have been issued and are
outstanding as of the date of this Agreement. 

  
 14 








 (b) Profits Interest Units. (i) Subject to the applicable terms and conditions
hereof, the Company may grant (at any time and from time to time) non-managing, non-voting Units designated as “Profits Interest Units” (such Units, “Profits Interest Units”) under the Management Incentive Plan or
Phantom Profits Interest Units under the Phantom Profits Interests Plan to one or more individuals rendering, or who will render, services for the benefit of the Company and/or its Subsidiaries. The terms and conditions of the Profits Interest Units
and the Phantom Profits Interest Units, which shall be set forth in the applicable Award Agreement in each case, shall be consistent with the terms and conditions of this Agreement and the Management Incentive Plan or the Phantom Profits Interests
Plan, as applicable, and shall, subject to the applicable terms and conditions hereof and thereof, otherwise be determined solely by the Board of Managers. Neither the terms nor the conditions applicable to any Profits Interest Unit need be
identical or similar to any other Profits Interest Unit. 
 (ii) Upon the issuance of Profits Interest Units pursuant
hereto, Schedule I will be deemed amended to reflect the issuance of such Profits Interest Units and the holder thereof and the Board of Managers will thereby be permitted to insert a replacement Schedule I hereto to reflect such amendment, subject
to the proviso set forth in the definition of Capital Contribution. 
 (iii) Without the prior written approval of
S&N and the Essex Members, acting in their capacity as Members, the Company shall not be permitted to issue Profits Interest Units, Phantom Profits Interest Units or any other form of employee, management or other service provider equity or
equity-related awards (such other forms of employee, management or other service provider equity or equity-related awards, collectively, “Other Management Equity Awards”) that could result in aggregate distributions to the holders
thereof in excess of 10% of the aggregate amount, if any, available for distribution pursuant to Section 10.05(a)(v) (such amount determined, solely for this purpose, as if there were no Phantom Profits Interest Units or Other Management Equity
Awards). Any purported issuance of Profits Interest Units, Phantom Profits Interest Units or Other Management Equity Awards in contravention of this Section 3.01(b)(iii) will be null and void ab initio. 

(iv) Notwithstanding anything else herein to the contrary, unless S&N and the Essex Members, acting in their capacity as
Members, expressly agree otherwise in writing: 
 (A) the Benchmark Amount for a specified Class of Profits Interest Units
shall not be less than the greater of (1) the fair market value of the assets of the Company, net of its liabilities, at the time the Class of Profits Interest Unit is issued (as determined in good faith by the Board of Managers), and
(2) $231,372,549.02; and 
 (B) the Benchmark Amount for each outstanding Class of Profits Interest Units shall be
increased if and when any Capital Contribution is made after the issuance of such Class of Profits Interest Units (other than the Capital Contributions contemplated by the OUS Contribution Agreement) by the amount of the fair market value of such
Capital Contribution. 

  
 15 








 (c) Subject to Section 3.05, Section 5.02(b) and Annex A hereto, from time to time
after the date hereof, the Board of Managers may cause the Company to offer and issue additional Units with such powers, preferences and rights, and subject to such qualifications, limitations and restrictions, as the Board of Managers may
determine; provided that the Company may not offer or issue (i) any additional EPR Units or any other Units with substantially similar powers, preferences and rights to those of the EPR Unit or (ii) any Company Securities pursuant to the
Management Incentive Plan other than the Profits Interest Units or pursuant to the Phantom Profits Interests Plan other than the Phantom Profits Interest Units. 

(d) The Units held by each Member as of the date hereof is set forth on Schedule I attached hereto, as the same may be amended from time to
time in accordance with the requirements of this Agreement or to reflect any changes resulting from any Transfers or other adjustments to the Units. 

Section 3.02 Certificates. All Units shall be issued in certificated form. Each certificate representing
Units (a “Certificate”) shall bear such legends as the Board of Managers may consider necessary or advisable to facilitate compliance with this Agreement, the Securities Act and any other securities law, including, without
limitation, legends referring to the transfer restrictions contained herein and stating that the Units represented by such Certificate have not been registered under the Securities Act. Each Certificate shall be executed by an authorized officer of
the Company on behalf of the Company and shall state the Company’s name, the name of the applicable Member, the number and type of Units represented by such Certificate, the date of issuance of the Certificate, the number of the Certificate and
such other information as determined by the Company as applicable for the Certificate. 
 Section 3.03 Additional Capital
Contributions. Except as expressly set forth in this Agreement, no Member shall be required to make any additional capital contributions to the Company. 

Section 3.04 Other Matters. (a) Except as otherwise provided in (and subject to the provisions of) this Agreement and except
for any distributions made to the Members according to their respective interests in distributions in accordance with Article 4 or Article 10 hereof, in each case made in compliance with this Agreement, no Member shall receive a return of any of its
Capital Contributions, or, in the case of the Investors, any of the amounts represented by such Investor’s Percentage Interest. Under circumstances requiring a return of any Capital Contributions, no Member shall have the right to receive
property other than cash except as may be specifically provided herein. 
 (b) No Member or any Affiliate thereof shall receive any interest,
salary or drawing with respect to its Capital Contributions or its Percentage Interest or for services rendered on behalf of the Company or otherwise in its capacity as a Member or otherwise, except as contemplated by this Agreement or the Related
Documents or any other agreement in writing with the Company approved by the Board of Managers in accordance with the requirements of Section 5.02. 

  
 16 








 (c) Except as provided herein, no Member shall have any right to (i) withdraw as a Member of
the Company, (ii) withdraw from the Company all or any part of such Member’s Capital Contributions, (iii) receive property other than cash in return for such Member’s Capital Contributions or (iv) receive any distribution
from the Company except in accordance with Article 4 or Article 10 hereof. 
 (d) Upon any Transfer of Units in accordance with the terms of
this Agreement (other than a Member Entity Transfer), the Transferee shall succeed to the Capital Account of the Transferor to the extent attributable to the Transferred Units. For the avoidance of doubt, in the case of a Preferred Transfer Event,
the Transferee shall not succeed to the Capital Account of the Transferor to the extent of the Accrued Preferred Distribution. 
 (e) If the
Company shall subdivide or split (whether by distribution or otherwise) the outstanding Preferred Units into a greater number of Units or combine or reclassify the outstanding Preferred Units into a smaller number of Units, the same subdivision,
split, combination or reclassification, as the case may be, shall be carried out on the outstanding Common Units, OUS Units and Profits Interest Units. By way of example, if the Preferred Units are split 10 to 1, then the Common Units, the OUS Units
and the Profits Interest Units will also be split 10 to 1. Upon the occurrence of any such adjustment to the Common Units, the OUS Units and the Profits Interest Units, the Company shall promptly (i) compute such adjustment in accordance with
the terms hereof and furnish to the holders of the Common Units, the OUS Units and the Profits Interest Units a certificate setting forth such adjustment and showing in reasonable detail the facts upon which such adjustment is based,
(ii) appropriately adjust Schedule I hereto and (iii) issue to each holder of Common Units, OUS Units or Profits Interest Units, upon the surrender of the Certificate or Certificates representing such holder’s Common Units, OUS Units
or Profits Interest Units at the time of such adjustment, a new Certificate or Certificates appropriately reflecting such adjustment. Adjustments shall be made successively whenever any event giving rise to such an adjustment under this
Section 3.04(e) shall occur. 
 (f) If the Company shall subdivide or split (whether by distribution or otherwise) the outstanding
Common Units or OUS Units into a greater number of Units or combine or reclassify the outstanding Common Units or OUS Units into a smaller number of Units, the same subdivision, split, combination or reclassification, as the case may be, shall be
carried out on the outstanding Units of the other types. By way of example, if the Common Units are split 10 to 1, then the OUS Units and the Profits Interest Units will also be split 10 to 1 (and, for the avoidance of doubt, the Preferred Units
will also be split 10 to 1 in accordance with Annex C hereto). Upon the occurrence of any such adjustment to the Common Units or the OUS Units, the Company shall promptly (i) compute such adjustment in accordance with the terms hereof and
furnish to the holders of the other type of Units a certificate setting forth such adjustment and showing in reasonable detail the facts upon which such adjustment is based, (ii) appropriately adjust Schedule I hereto and
(iii) issue to each holder of the other type of Units, upon the surrender of the Certificate or Certificates representing such holder’s Units at the time of such adjustment, a new Certificate or Certificates appropriately reflecting such
adjustment. Adjustments shall be made successively whenever any event giving rise to such an adjustment under this Section 3.04(f) shall occur. 

(g) If the Company shall subdivide or split (whether by distribution or otherwise) the outstanding Profits Interest Units into a greater number
of Units or combine or reclassify the outstanding Profits Interest Units into a smaller number of Units, the same subdivision, split, 

  
 17 








 
combination or reclassification, as the case may be, shall be carried out on the outstanding Units of the other types. By way of example, if the Profits Interest Units are split 10 to 1, then the
Common Units, and the OUS Units will also be split 10 to 1 (and, for the avoidance of doubt, the Preferred Units will also be split 10 to 1 in accordance with Annex C hereto). Upon the occurrence of any such adjustment to the Profits Interest
Units, the Company shall promptly (i) compute such adjustment in accordance with the terms hereof and furnish to the holders of the other type of Units a certificate setting forth such adjustment and showing in reasonable detail the facts upon
which such adjustment is based, (ii) appropriately adjust Schedule I hereto and (iii) issue to each holder of the other type of Units, upon the surrender of the Certificate or Certificates representing such holder’s Units at the time
of such adjustment, a new Certificate or Certificates appropriately reflecting such adjustment. Adjustments shall be made successively whenever any event giving rise to such an adjustment under this Section 3.04(g) shall occur. 

(h) The holders of the Common Units and OUS Units shall be entitled to one vote per Common Unit or OUS Unit on all matters on which the holders
of the Common Units and OUS Units are entitled to vote. 
 Section 3.05 Preemptive Rights. (a) The Board of Managers shall
have the authority to issue Company Securities in such amounts and at such purchase prices per Company Security as determined by the Board of Managers, subject to the provisions of this Section 3.05 and Section 5.02(b). Subject to
Section 3.05(f), the Company shall deliver written notice (an “Issuance Notice”) to each Investor of any proposed issuance by the Company of any Company Securities at least 20 days prior to the proposed issuance date. The
Issuance Notice shall specify the cash price at which such Company Securities are to be issued and the other material terms of the issuance. Subject to Section 3.05(e) and Section 3.05(f), each Investor shall be entitled to purchase up to
such Investor’s Percentage Interest of the Company Securities proposed to be issued, at the price and on the terms specified in the Issuance Notice. 

(b) An Investor shall deliver written notice of its election to purchase such Company Securities to the Company and each other Investor
within 15 days of receipt of the Issuance Notice. Such delivery of notice (which notice shall specify the number (or amount) of Company Securities to be purchased by the Investor submitting such notice) to the Company shall constitute exercise by
such Investor of its rights under this Section 3.05 and a binding agreement of such Investor to purchase, at the price and on the terms specified in the Issuance Notice, the number (or amount) of Company Securities specified in such
Investor’s notice, and, in the case of S&N, any election made pursuant to Section 3.05(e). If, at the termination of such 15-day period, any Investor shall not have exercised its rights to purchase any of its pro
rata percentage of such Company Securities, such Investor shall be deemed to have waived all of its rights under this Section 3.05 with respect to the purchase of such Company Securities (but, for the avoidance of doubt, shall not
have waived its rights with respect to any future purchase of Company Securities). To the extent that any Investor does not exercise its rights under the first and second sentences of this Section 3.05(b) in full, the Company shall provide the
Investors who have elected to exercise their rights in full with the opportunity to purchase the remaining Company Securities which were the subject of the Issuance Notice (the “Remaining Securities”). In such event, such Investors
may elect to purchase any or all of the Remaining Securities; provided that each such electing Investor shall receive its proportionate share of the Remaining Securities based on the aggregate number of Company Securities
such Investors as a group elect to purchase if such number is more than the number or amount of Remaining Securities. 

  
 18 








 (c) The Company shall have 90 days from the date of the Issuance Notice to consummate the
proposed issuance of any or all of such Company Securities that the Investors have not elected to purchase at the price and upon terms that are not less favorable to the Company than those specified in the Issuance Notice; provided that, if such
issuance is subject to regulatory approval, such 90-day period shall be extended until the expiration of five Business Days after all such approvals have been received, but in no event later than 180 days from the date of the Issuance Notice. The
closing of any purchase of such Company Securities that Investors have elected to purchase pursuant to such Issuance Notice shall take place at the same time as the issuance to non-Investors. 

(d) If the Investors have elected to purchase all of the Company Securities proposed to be issued at any one time pursuant to this
Section 3.05, the consummation of such purchase shall take place as soon as practicable (but in no event more than 45 days) following the receipt of all notices from the Investors indicating such election; provided that if such purchase is
subject to regulatory approval, such 45-day period shall be extended until the expiration of 5 Business Days after all such approvals have been received, but in no event later than 90 days following the receipt of such election notices. At the
consummation of the issuance of such Company Securities, the Company shall issue the Company Securities to be purchased by each Investor exercising preemptive rights pursuant to this Section 3.05 registered in the name of such Investor, against
payment by such Investor of the purchase price for such Company Securities as specified in the Issuance Notice. If the Company proposes to issue any Company Securities after such 45-day (or up to 90-day, as applicable) period (as it may be extended
as provided above), it shall again comply with the procedures set forth in this Section 3.05. 
 (e) Notwithstanding the foregoing, in lieu
of paying in cash the entire purchase price of any Company Securities that S&N has elected to purchase in any issuance of Company Securities pursuant to this Section 3.05, S&N may elect, in its sole discretion, to pay up to 25% of the
aggregate purchase price of such Company Securities by Transferring to the Company debt obligations of the Company held by S&N in an aggregate principal amount equal to the portion of the aggregate purchase price that S&N has elected to pay
pursuant to this Section 3.05(e). 
 (f) Notwithstanding the foregoing, no Investor shall be entitled to purchase Company Securities as
contemplated by this Section 3.05 in connection with issuances of (i) Company Securities to employees of the Company or any of its Subsidiaries pursuant to the Management Incentive Plan (and for the avoidance of doubt, Phantom Units
pursuant to the Phantom Profits Interest Plan), (ii) Converted Common Units pursuant to conversion rights as set forth in Annex C, (iii) Preferred Units and OUS Units pursuant to the OUS Contribution Agreement, or (iv) Company
Securities as consideration for any bona fide, arm’s-length direct or indirect merger, acquisition or similar transaction approved by the Board of Managers in accordance with the provisions of this Agreement. The Company shall not be obligated
to consummate, nor be liable to any Investor if the Company has not consummated, any proposed issuance of Company Securities pursuant to this Section 3.05 for whatever reason, regardless of whether it shall have delivered an Issuance Notice in
respect of such proposed issuance. 

  
 19 








 (g) This Section 3.05 shall terminate upon consummation of an Initial Public Offering. 

Section 3.06 Agreement to be Bound. No Transfer of Units otherwise permitted pursuant to this Agreement (other than any Transfer
pursuant to a Public Offering) shall be effective unless prior (and as a condition) to such Transfer, the Transferee (if not already a party to this Agreement) shall have executed and delivered to the Company an instrument or instruments reasonably
satisfactory to the Board of Managers confirming that such Transferee has agreed to be bound as a “Member” by the terms of this Agreement, a copy of which instrument shall be maintained on file with the Secretary of the Company and
shall include the address of such Transferee to which notices hereunder shall be sent; provided, however, that, in the event of any Member Entity Transfer, the applicable Member shall remain bound by the terms of this Agreement, and
the applicable Transferee shall not be bound as a “Member” by the terms of this Agreement solely by reason of such Transfer. Furthermore, no Transfer under this Agreement shall relieve the Transferor (including, in the case of a
Member Entity Transfer, the applicable Member) from any of its obligations hereunder arising prior to such Transfer, and such Transferor and Transferee shall be jointly and severally liable with respect to any such obligations. Prior to issuing
Units to any new Members, the Company will require such Member to agree to be bound by this Agreement in the manner described above. 

ARTICLE 4 
 DISTRIBUTIONS AND
ALLOCATIONS 
 Section 4.01 Distributions. The Company may periodically make distributions of available cash to the Members
holding Preferred Units, Common Units and OUS Units at such times and in such amounts as are approved by the Board of Managers, subject to the applicable requirements of Section 5.02(b) and Annex C. Except (a) as otherwise set forth
in this Article 4 or (b) for the payment of Preferred Distributions and Accrued Preferred Distributions (in each case, in accordance with the terms of this Agreement, and subject to the restrictions contained in this Agreement and the S&N
Note), each distribution shall be made to the holders of Preferred Units, the Common Units and the OUS Units ratably among such holders based upon the number of Units held by each such holder as of the time of such distribution. Distributions
pursuant to this Section 4.01 shall be made to the holders of record of Preferred Units, Common Units and OUS Units as they appear on Schedule I at the close of business on the applicable record date, which shall be a date not less than
10 days nor more than 60 days before the date on which the distribution is to be made, as fixed by the Board of Managers. 

Section 4.02 Tax Distributions. (a) Notwithstanding any other provision of this Agreement, the Board of Managers shall cause
the Company to make distributions to each Member (including, for the avoidance of doubt, Profits Interest Members, regardless of whether such Members’ Profits Interest Units have vested) at such times as shall be reasonably determined to enable
such Member to pay federal, state and local income taxes, including estimated taxes, in an amount equal to the product of (i) the net profit allocated to such Member pursuant to Section 4.06 and (ii) the Assumed Tax Rate (each such
distribution, a “Tax Distribution”). 

  
 20 








 (b) Notwithstanding anything to the contrary otherwise set forth in this Agreement, (i) Tax
Distributions shall not be treated as an advance distribution of amounts otherwise distributable to the Members pursuant to Section 4.01 and Section 10.05 and shall not reduce such amounts and (ii) any distribution to a 

Member pursuant to this Agreement (including a distribution pursuant to Section 10.05) shall be treated first as a Tax Distribution made
to such Member in an amount equal to the aggregate amount of Tax Distributions required to be made to such Member pursuant to this Section 4.02 from the date of this Agreement that have not previously been made. 

Section 4.03 Distributions in Violation of Delaware Law. Notwithstanding any provision of this Agreement to the contrary, the
Board of Managers shall not be required to make a distribution to a Member if such distribution would violate Delaware Law or any other Applicable Law. 

Section 4.04 Amounts Withheld. The Company is authorized to withhold from distributions, or with respect to allocations, to the
Members and to pay over to any federal, state, local or foreign government any amounts which it reasonably determines may be required to be so withheld pursuant to the Code or any provisions of any other federal, state, local or foreign law. All
amounts withheld pursuant to the Code or any provision of any state, local or foreign tax law with respect to any allocation or distribution to any Member shall be treated as amounts distributed to such Member pursuant to this Article for all
purposes under this Agreement. The Company shall provide each Member with documentation substantiating that such withholdings were in fact paid to the relevant governmental entity. Each Member shall indemnify the Company for any Damages incurred or
sustained by the Company with respect to any amounts required to be withheld from any distributions, or with respect to allocations, to such Member and any liability (including penalties, interest and expenses) arising therefrom or with respect
thereto. 
 Section 4.05 Dissolution. Upon dissolution and winding up of the Company, the Company shall make distributions in
accordance with Section 10.04. 
 Section 4.06 Allocations. (a) After taking into account the special allocations set
forth in Section 4.07, and subject to Section 4.06(b) and Section 4.06(c), profits and losses for any Fiscal Year shall be allocated among the Members in such a manner that, as of the end of such Fiscal Year, the sum of (i) the
Capital Account of each Member, (ii) such Member’s share of minimum gain (as determined according to Treasury Regulation Section 1.704-2(g)) and (iii) such Member’s partner nonrecourse debt minimum gain (as defined in
Treasury Regulation Section 1.704-2(i)(3)) shall be equal to the respective net amounts, positive or negative, which would be distributed to them or for which they would be liable to the Company under this Agreement, determined as if the
Company were dissolved, its affairs wound up and (A) all of the assets of the Company were sold on the last day of such Fiscal Year for cash equal to their respective Book Values (except that assets of the Company actually sold during such
Fiscal Year shall be treated as sold for the consideration received therefor), (B) all Company liabilities were satisfied (limited, with respect to each “partner nonrecourse liability” and “partner nonrecourse debt,” as
defined in Treasury Regulation Section 1.704-2(b)(4), to the Book Value of the assets of the Company securing such liabilities) and (C) the net assets were immediately distributed to 

  
 21 








 
the Members in accordance with Section 10.05. For purposes of allocating profits and losses pursuant to this Section 4.06 (and Section 4.07, to the extent applicable), all
outstanding Profits Interest Units shall be treated as vested Profits Interest Units (and therefore, shall be treated as outstanding for purposes of this Agreement, and shall be allocated a share of the Company’s profit and loss in accordance
with this Article 4); provided, that, if a Member’s unvested Profits Interest Units are forfeited and the Company has made a Safe Harbor Election (as defined in Section 4.10(b)) that applies to the forfeited Profits Interest Units,
then profits and losses arising in the Fiscal Year in which such forfeiture occurs shall be allocated in compliance with then applicable IRS guidance with respect to Safe Harbor Elections. 

(b) If any allocation of losses for any Fiscal Year would cause a Member to have an adjusted capital account deficit (determined according to
Treasury Regulation Section 1.704-1(b)(2)(ii)(d)), those losses instead shall be allocated to the other Members pro rata until their Capital Accounts are reduced to zero, and any remaining losses will be allocated to each Member in accordance
with the relative number of Units held by such Member. 
 (c) Notwithstanding the foregoing, the current profits and losses of the
Company (determined, for the avoidance of doubt, without regard to any unrealized income, gains, losses, deductions and expenditures) that would otherwise be allocated pursuant to Section 4.06(a) by reference to Section 10.05(a)(v)(C), if
any, shall be allocated pursuant to this Section 4.06(c) solely to the holders of the Common Units and the holders of the OUS Units by reference to the Outstanding Common Percentage and the Outstanding OUS Percentage, respectively;
provided that, for the avoidance of doubt, the allocations made pursuant to this Section 4.06(c), and distributions made pursuant to Section 10.05(a)(v) as a result thereto, shall not impact in any way (i) the amount of profit
and/or loss that is allocable to any of the Essex Members pursuant to this Agreement or (ii) the amount and/or priority of any distributions from the Company to which any of the Essex Members are entitled pursuant to this Agreement. The parties
hereto intend that allocations made pursuant to this Section 4.06(c) shall result in aggregate allocations consistent with the distribution requirements of Section 10.05(a)(v)(C). 

Section 4.07 Special Allocations. (a) Prior to any allocations required pursuant to Section 4.06(a) hereof, the Members
shall be allocated items of income, gain, loss or deduction that would be required to be so allocated under (i) Treasury Regulation Section 1.704-2(t) and (g) (relating to allocations required in connection with a minimum gain
chargeback), (ii) Treasury Regulation Section 1.704-2(i) (relating to allocations required in connection with a partner minimum gain chargeback), (iii) Treasury Regulation Section 1.704-1(b)(2)(ii)(d)(4), (5), or (6) and
Treasury Regulation Section 1.704-1 (relating to allocations required in connection with a qualified income offset) and (iv) as otherwise required pursuant to Section 704(b) of the Code and the Treasury Regulations promulgated
thereunder. 
 (b) The allocations set forth above in Section 4.06(b) and Section 4.07(a) (collectively, the
“Regulatory Allocations”) are intended to comply with certain requirements of the Treasury Regulations. It is the intent of the Members that, to the extent possible, all Regulatory Allocations shall be offset either with other
Regulatory Allocations or with special allocations of other items of Company income, gain, loss or deduction pursuant to this Section 4.07(b). Therefore, notwithstanding any other provisions of this Article 4 (other than the Regulatory
Allocations), the Board of Managers shall make such offsetting special allocations of  

  
 22 








 
Company income, gain, loss or deduction in whatever manner it determines appropriate so that, after such offsetting allocations are made, each Member’s Capital Account balance is, to the
extent possible, equal to the Capital Account balance such Member would have had if the Regulatory Allocations were not part of this Agreement and all Company items were allocated pursuant to this Article 4 without regard to the Regulatory
Allocations. 
 Section 4.08 Tax Allocations. (a) Except as otherwise provided in this Section 4.08 or required by the
Code or other Applicable Law, the income, gains, losses, deductions and credits of the Company will be allocated, for federal, state and local income tax purposes, among the Members in the same proportions as such items are allocated pursuant to
Section 4.06. 
 (b) Items of Company taxable income, gain, loss and deduction with respect to any property contributed to the
capital of the Company in connection with its formation shall, solely for income tax purposes, be allocated among the Members in accordance with Section 704(c) of the Code under the “traditional method” so as to take account of
any variation between the adjusted basis of such property to the Company for federal income tax purposes and its Book Value. 
 (c) If
the Book Value of any Company asset is adjusted pursuant to the requirements of Treasury Regulations Section 1.704-1(b)(2)(iv)(e) or (f), subsequent allocations of items of taxable income, gain, loss and deduction with respect to such asset
shall take account of any variation between the adjusted basis of such asset for federal income tax purposes and its Book Value in the same manner as under Section 704(c) of the Code. 

(d) Allocations pursuant to this Section 4.08 are solely for purposes of federal, state, and local income taxes and shall not affect, or
in any way be taken into account in computing, any Member’s Capital Account or share of profits, losses, other items, or distributions pursuant to any provision hereof. 

(e) The Members acknowledge the income tax consequences of the allocations made by this Article 4 and hereby agree to be bound by the
provisions of this Article 4 in reporting their respective shares of Company income and loss for income tax purposes. 

Section 4.09 Reimbursement of Essex Member Administrative Expenses. Each Essex Member that (a) is treated as a
corporation for U.S. federal income tax purposes, (b) was formed solely for the purpose of holding Units, and (c) does not hold any investment other than Units or undertake any activities except with respect to holding Units, shall be
entitled to reimbursement from the Company for reasonable administrative expenses incurred in connection with the formation of such Essex Member and its investment in the Company that would not have been incurred if the Essex Funds were to invest
directly in a corporate entity without utilizing an Essex Member (including the preparation and filing of tax returns); provided that the aggregate of all payments made by the Company under this Section 4.09 relating or attributable to
such expenses incurred by the Essex Members in any Fiscal Year shall not exceed $350,000. Reimbursement payments made under this Section 4.09 shall be treated as “guaranteed payments” for U.S. federal income tax purposes. 

  
 23 








 Section 4.10 Provisions Relating to Profits Interest Units. (a) Profits Interest
Units may be granted in accordance with Section 3.01(b) in exchange for services provided or to be provided to the Company and/or its Subsidiaries. Consistent with the foregoing, Profits Interest Units are intended to be treated as
“profits interests” under IRS Revenue Procedure 93-27 and IRS Revenue Procedure 2001-43 and the provisions hereof shall be interpreted and applied consistently therewith. Subject to Section 3.01(b)(iv), if a Profits Interest Unit is
issued after the date hereof, then the Board of Managers may make appropriate adjustments to the terms of such Profits Interest Unit in order for such Profits Interest Unit to be treated as a “profits interest” as described in the
immediately preceding sentence, including adjusting the Benchmark Amount in respect of such Profits Interest Units (e.g., increasing the Benchmark Amount if Capital Contributions are made subsequent to the issuance of such Profits Interest Unit).

 (b) Each Member hereby authorizes and directs the Company to make an election (the “Safe Harbor Election”) to
value any Profits Interest Units issued by the Company as compensation for services at liquidation value as the same may be permitted pursuant to or in accordance with temporarily or finally promulgated successor rules to Proposed Regulations
Section 1.83-3(1) and the proposed Revenue Procedure set forth in IRS Notice 2005-43 (the “IRS Notice”). For purposes of making such Safe Harbor Election, the Tax Matters Member is hereby designated as the “partner who has
responsibility for federal income tax reporting” by the Company and, accordingly, execution of such Safe Harbor election by the Tax Matters Member constitutes execution of a “Safe Harbor Election” in accordance with
Section 3.03(1) of the IRS Notice. The Company and each Member shall comply with all requirements of the Safe Harbor Election described in the IRS Notice, including the requirement that each Member prepare and file all federal income tax
returns reporting the income tax effects of each interest in the Company issued by the Company covered by the Safe Harbor Election in a manner consistent with the requirements of the IRS Notice. 

(c) Each Member hereby authorizes the Board of Managers to amend Section 4.10(b) to the extent necessary to achieve substantially the same
tax treatment with respect to any interest in the Company transferred to a service provider by the Company in connection with services provided to the Company and/or its Subsidiaries as set forth in Section 4 of the IRS Notice (e.g., to reflect
changes from the rules set forth in the IRS Notice in subsequent IRS guidance), provided that such amendment is not materially adverse to such Member (as compared with the after-tax consequences that would result if the provisions of the IRS Notice
applied to all interests in the Company transferred to a service provider by the Company in connection with services provided to the Company and/or its Subsidiaries). A Member’s obligations to comply with the requirements of this
Section 4.10 shall survive such Member’s ceasing to be a Member of the Company and/or the termination, dissolution, liquidation and winding up of the Company, and, for purposes of this Section 4.10, the Company shall be treated as
continuing in existence. 

  
 24 








 ARTICLE 5 

THE BOARD OF MANAGERS 

Section 5.01 Board of Managers. (a) Except as otherwise provided in this Agreement, the business and
affairs of the Company shall be managed by or under the direction of a board of managers (the “Board of Managers”), which shall initially be composed of nine managers (each, a “Manager”). The Board of
Managers shall be designated as follows: 
 (i) The Essex Members may designate five Managers; 

(ii) S&N may designate two Managers so long as S&N’s Percentage Interest is greater than or equal to 15%; 

(iii) The Company’s Chief Executive Officer shall be a Manager; and 

(iv) The Chairman of the Board of Managers (the “Chairman”) shall be a Manager. 

(b) The Chairman shall be selected by the Essex Members, provided that the Chairman shall at all times be Independent.
“Independent” with respect to a Manager, shall have the meaning assigned to the term “independent director” as such term is defined from time to time in the New York Stock Exchange’s listing standards (or the
principal national securities exchange on which the Company’s common equity is then traded) and is not an “affiliate” or an “associate” (as such terms are defined in Rule 12b-2 of the Securities Exchange Act of 1934, as
amended (“Exchange Act”)) or any member of the “immediate family” (as such term is defined in Rule 16a-1 of the Exchange Act) of a director or executive officer of the Company or any of the Essex Members or their
respective Affiliates and shall not have (or have had during the past three years) any employment arrangement or other material commercial arrangement with any such person. 

(c) The Company and each Member will take all actions that are necessary and within its power in order to ensure that the composition of the
Board of Managers is as set forth in Section 5.01(a) and Section 5.01(b). 
 (d) Except as otherwise expressly provided in this
Agreement, the Board of Managers shall have the power on behalf and in the name of the Company to carry out any and all of the purposes of the Company described in Section 2.03 and to perform all acts which it may, in its discretion, deem
necessary or desirable in furtherance of such purposes. 
 Section 5.02 Quorum and Manner of Acting. (a) Except as
otherwise expressly provided in this Agreement, (i) the presence (in person or by telephone) of a majority of the total number of Managers shall constitute a quorum for the transaction of business and (ii) the affirmative vote of at least
a majority of the Managers present at a meeting at which a quorum exists shall be the act of the Board of Managers. The Chairman of the Board of Managers shall appoint a person to act as secretary of each meeting of the Board of Managers and keep
the minutes thereof. Any Manager may designate another individual to attend a meeting of the Board of Managers and such individual shall have the full power and authority to take any action which such Manager would otherwise be entitled to take.

 (b) Without limiting the generality of Section 5.02(a), except as otherwise expressly provided in this Agreement or any Related
Document, any material matters relating to the management of the Company, including the actions set forth on Annex A hereto, shall require the approval of the Board of Managers and where applicable shall be subject to the approval rights of S&N
acting in its capacity as a Member as set forth on Annex A. 

  
 25 








 Section 5.03 Time and Place of Meetings. The Board of Managers shall hold its
meetings at least bi-monthly, at such place, either within or without the State of Delaware or by telephone (provided that at least four meetings per year shall be held in person), and at such time as may be determined from time to time by the Board
of Managers. Each Investor shall use reasonable efforts to cause the Managers appointed by such Investor to attend each meeting of the Board of Managers. 

Section 5.04 Regular Meetings. Notice of the place and time of any regular meeting of the Board of Managers shall be given to each
Manager by the Company at least five Business Days before the meeting date, and such notice shall include an agenda, any proposed resolutions and appropriate background information regarding the matters to be acted upon. The business conducted at
any regular meeting shall be limited to the items set forth in the agenda. The Board of Managers shall schedule its meetings using good faith efforts to accommodate any scheduling conflicts of the Managers. Regular meetings of the Board of Managers
shall only be scheduled for a Business Day during normal business hours, unless otherwise agreed by the Essex Members and S&N. 

Section 5.05 Special Meetings. Special meetings of the Board of Managers may be called upon the written request of any two
Managers. Notice of special meetings of the Board of Managers shall be given to each Manager at least five Business Days before the meeting date in such manner as is determined by the Board of Managers, and shall include a statement of the purpose
or purposes of such special meeting, any proposed resolutions and appropriate background information regarding the matters to be acted upon. A written waiver of any such notice signed by the Manager entitled thereto, whether before or after the time
stated therein, shall be deemed equivalent to notice. Attendance of a Manager at a meeting shall constitute a waiver of notice of such meeting, except when such Manager attends the meeting for the express purpose of objecting, at the beginning of
the meeting, to the transaction of any business because the meeting is not lawfully called or convened. The business conducted at any special meeting shall be limited to the purpose or purposes set forth in the notice thereof, unless otherwise
agreed by the Essex Members and S&N. 
 Section 5.06 Committees. Subject to Section 5.02(b), the Board of Managers may
designate one or more committees. Any such committee, to the extent provided in the resolution of the Board of Managers, shall have and may exercise all the powers and authority of the Board of Managers in the management of the business and affairs
of the Company, subject to the applicable approval rights of S&N pursuant to Annex A. Each committee shall keep regular minutes of its meetings and report the same to the Board of Managers when requested by any Investor. 

Section 5.07 Subsidiaries. Unless otherwise agreed by the Essex Members and S&N, the board of directors or comparable
governing body of each Subsidiary of the Company with a board of directors or equivalent body shall be comprised of the individuals who are serving as Managers in accordance with Section 5.01. The other provisions of this Article 5 (including
Annex A) shall apply mutatis mutandis to each such Subsidiary of the Company. 

  
 26 








 Section 5.08 Action by Consent. Any action required or permitted to be taken at any
meeting of the Board of Managers or of any committee thereof may be taken without a meeting, if all members of the Board of Managers or committee, as the case may be, consent thereto in writing, and the writing or writings are filed with the minutes
of proceedings of the Board of Managers or committee, as the case may be. 
 Section 5.09 Telephonic Meetings. Subject to
Section 5.03, members of the Board of Managers or any committee thereof may participate in a meeting of the Board of Managers or such committee, as the case may be, by means of conference telephone or similar communications equipment by means
of which all persons participating in the meeting can hear each other, and such participation in a meeting shall constitute presence in person at the meeting. 

Section 5.10 Resignation. Any Manager may resign at any time by giving written notice to the Board of Managers of the Company. The
resignation of any Manager shall take effect upon receipt of notice thereof or at such later time as shall be specified in such notice; and unless otherwise specified therein, the acceptance of such resignation shall not be necessary to make it
effective. 
 Section 5.11 Term; Vacancies. Each Manager shall hold office until his or her successor is appointed, or until his
or her earlier death, resignation or removal. Any Manager may be removed, with or without cause, at any time by the Investor or the Affiliate of such Investor that appointed such Manager. Vacancies on the Board of Managers may only be filled by the
Investor or the Affiliate of such Investor that appointed the departing Manager. In connection with each appointment or removal of a Manager, the Investor or the Affiliate of such Investor making such appointment or removal shall give written notice
thereof to the Company and the other Members. 
 ARTICLE 6 

ACCOUNTING AND TAX MATTERS 

Section 6.01 Auditors and Financial Statements. (a) The Company’s independent public accountants shall at all times be
an independent public accounting firm of nationally recognized standing, as selected by the Board of Managers from time to time. 

(b) The Company shall adopt and follow IFRS, consistently applied, and all financial terms used herein shall, to the extent not
otherwise defined be interpreted according to IFRS; provided that, if the Board of Managers determines that the Company shall adopt and follow GAAP in lieu of IFRS, the Company shall thereafter adopt and follow GAAP, consistently applied, and
all financial terms used herein shall, to the extent not otherwise defined, be interpreted according to GAAP in accordance with their common usage by auditors in the United States. Without limitation of the other rights of the Members under this
Agreement, each Investor and its independent auditors shall be entitled to have reasonable access to and consultation with the Company’s management (including its finance and accounting staff) and the Company’s independent public
accountants and, as long as S&N and its Permitted Transferees hold, in the aggregate, at least 9.9% of the outstanding Units (determined without regard to the EPR Unit and any outstanding Profits Interest Units), such Investor shall be entitled
to review such accountants’ work papers (to the extent made available to the Company) and the  

  
 27 








 
information made available to the Company in connection with the preparation and audit of the Company’s financial statements. The Company shall cause its independent public accountants to
make such work papers and information available to the Investors and otherwise to cooperate with the Investors and their independent auditors as reasonably requested in accordance with this Section 6.01(b). The Company shall afford each
Investor and its auditors and other authorized representatives such other reasonable access to the Company’s books of account, financial and other records as an Investor may reasonably request upon reasonable prior notice and during normal
business hours of the Company. 
 Section 6.02 Partnership for Tax Purposes. The Members hereby agree that the Company shall be
treated as a partnership for tax purposes under United States federal, state and local income tax laws or other laws, and further agree not to take any position or to make any election, in a tax return or otherwise, inconsistent herewith. Neither
the Company nor any Member shall elect to treat the Company as an association taxable as a corporation without the prior affirmative vote or unanimous written consent of all of the Investors. 

Section 6.03 Taxable Year. The Company’s accounting period for federal income tax purposes shall be the Fiscal Year, unless
the Board of Managers shall determine otherwise (subject to Section 5.02) in compliance with Applicable Law. 
 Section 6.04
Tax Matters Member. (a) Generally. The Tax Matters Member shall be responsible for undertaking the statutory responsibilities of the “Tax Matters Partner” under Subchapter C of Section 63 of Subtitle F of the
Code (as set forth in the Code and the Treasury Regulations), as well as such other responsibilities as are assigned to it pursuant to this Agreement. The Tax Matters Member shall act in good faith with regard to the best interests of each of the
Members in carrying out the responsibilities assigned to it pursuant to this Section 6.04(a). 
 (b) Designation of Tax Matters
Member. Beluga I is hereby designated as the Tax Matters Member of the Company. 
 (c) Filing of Returns. The Tax Matters Member
shall be responsible for (i) selecting the Return Preparer; provided that, as long as S&N and its Permitted Transferees hold, in the aggregate, at least 9.9% of the outstanding Units (determined without regard to the EPR Unit and any
outstanding Profits Interest Units), such selection shall be subject to the approval of S&N, which shall not be unreasonably withheld, conditioned or delayed, and (ii) for the timely filing of all returns relating to taxes of the Company
and its Subsidiaries. All income and franchise tax returns of, or relating to the Company and its Subsidiaries, shall be provided to S&N for review and comment not later than 60 Business Days prior to the due date (including extensions). S&N
shall be entitled to meet and discuss all income and franchise tax matters relating to the Company and its Subsidiaries with the Return Preparer and Tax Matters Member, and provide comments not later than 30 Business Days prior to the due date
(including extensions). As long as S&N and its Permitted Transferees hold, in the aggregate, at least 9.9% of the outstanding Units (determined without regard to the EPR Unit and any outstanding Profits Interest Units), the Tax Matters Member
shall not file any tax return of the Company without S&N’s prior written consent, which shall not be unreasonably withheld, conditioned or delayed. S&N shall be given reasonable access to all income and franchise tax returns, work
papers, supporting materials, 

  
 28 








 
written communications with the Service or any other taxing authority and other materials relating to income and franchise tax matters of the Company and its Subsidiaries. The Company shall, or
shall cause the Return Preparer to, deliver to each Member and, if necessary, each former Member, prior to April 15th of each year or thereafter as soon as reasonably practicable, Internal Revenue Service Schedule K-1 (or substantially similar
report setting forth in sufficient detail information which shall enable such Member or former Member to prepare its federal and state income tax returns). Further, the Company shall, or shall cause the Return Preparer to, provide S&N
information and access to information concerning the Company and its Subsidiaries that S&N reasonably requests in order for it to determine its federal, state, local, and foreign tax liability and timely file any tax returns (including estimated
tax and information returns). 
 (d) Audits and Administrative and Judicial Proceedings. (i) Subject to the following sentence,
the Tax Matters Member is authorized and required to represent the Company, its Subsidiaries, or any combination thereof in connection with any proceeding relating to any of them with the Service and any other taxing authority. In the event that the
Company shall be the subject of a partnership-level audit by any federal, state or local taxing authority (such as an audit pursuant to the TEFRA audit rules of Subchapter C of Chapter 63 of the Internal Revenue Code), to the extent that the Company
is treated as an entity for purposes of such audit (including administrative settlement and judicial review), the Tax Matters Member, subject to Section 6.04(d)(ii), shall be authorized to act for, and its decision shall be final and binding
upon, the Company and each Member thereof; provided, however, that the Tax Matters Member shall take such action as may be necessary to cause each other Member to become a “notice partner” within the meaning of Section 6231(a)(8) of
the Code. 
 (ii) With respect to communications between the Company or any Subsidiary and the Service or any other taxing
authority regarding any income or franchise tax of the Company or any Subsidiary (including with respect to any audit described in Section 6.04(d)(i) or Section 6.04(d)(iii)), the Tax Matters Member shall, or shall cause the Return
Preparer to: (A) mail a copy of any written communication to each Member within 10 Business Days of the receipt or sending of such written communication; (B) summarize for each Member any significant verbal communication within 10 Business
Days of such communication; and (C) permit each Member (other than the Profits Interest Members, unless such communications specifically relate to such Profit Interest Member’s rights and obligations hereunder) to have an opportunity to
participate in such communications, to the extent reasonably practicable. S&N shall have the reasonable opportunity to participate in any communication, including any conversation or meeting, with any taxing authority. As long as S&N and its
Permitted Transferees hold, in the aggregate, at least 9.9% of the outstanding Units (determined without regard to the EPR Unit and any outstanding Profits Interest Units), S&N’s consent, not to be unreasonably withheld, conditioned or
delayed, shall be required prior to: (1) the filing of a request for an administrative adjustment, (2) prior to the filing of a request for judicial review of an administrative adjustment and (3) agreeing to an extension of the
statute of limitations for any assessment. S&N’s consent, not to be unreasonably withheld, conditioned or delayed, shall be required prior to agreeing to any settlement of any income or franchise tax where the share of S&N and its
Permitted Transferees, taken together, of the item or items at issue with respect to all tax years under examination is, in the aggregate, in excess of $250,000. 

  
 29 








 (iii) Notwithstanding anything to the contrary in Section 6.04(e), S&N
and the S&N Blocker shall indemnify the Tax Matters Member, the Company and their respective Affiliates against, and hold the Tax Matters Member, the Company and their respective Affiliates harmless from, any and all Damages actually incurred or
sustained by Tax Matters Member, the Company and any of their respective Affiliates in connection with an audit, litigation or other similar proceeding with respect to taxes or any tax return of the Company to the extent such Damages arise from the
allocation requirement in Section 4.06(c) or the distribution requirement in Section 10.05(a)(v)(C); provided that, without limiting the rights of S&N otherwise provided herein, S&N shall have the right to participate in (but not
control) any such audit, litigation or other similar proceeding to the extent related to the allocation requirement in Section 4.06(c) or the distribution requirement in Section 10.05(a)(v)(C). 

(e) Costs. All reasonable out-of-pocket expenses incurred by the Tax Matters Member and S&N in connection with the matters described
in Section 6.04(d) shall be paid or reimbursed by the Company. If the Company does not have sufficient assets to pay any such costs, then the Investors shall contribute all needed funds for the prosecution of the audit, administrative
settlement or judicial review within 10 Business Days upon call of the Tax Matters Member, which call shall require that such contributions be made by the Investors in accordance with their Percentage Interests for the tax period under examination
(or the arithmetic average of their Percentage Interests for the tax period under examination if more than one taxable year shall be under examination). 

(f) Survival. The provisions of Sections 6.04(a)-6.04(e) shall be continuing covenants that shall survive the winding up and dissolution
of the Company. 
 (g) Tax Elections and Schedules. (i) Tax Elections. The Company shall make any tax elections as the
Board of Managers may determine necessary; provided that, as long as S&N and its Permitted Transferees hold, in the aggregate, at least 9.9% of the outstanding Units (determined without regard to the EPR Unit and any outstanding Profits
Interest Units), any such elections may only be made with the prior written approval of S&N, which shall not be unreasonably withheld, conditioned or delayed; and provided, further, that the Company shall (A) make an election pursuant to
Section 754 of the Code and (B) elect to use the “traditional method” under Section 704(c) of the Code to take account of any variation between the adjusted basis of any property contributed to the Company for federal income
tax purposes and its Book Value. 
 (ii) Tax Schedules. S&N and the Essex Members agree that the allocation
of value and tax basis for purposes of Section 704(c) of the Code among the assets contributed by S&N pursuant to the S&N-Company Contribution Agreement on the date hereof shall be as set forth on Annex E and that the allocation
of value and tax basis for purposes of Section 704(c) of the Code among the assets contributed by the Essex Members pursuant to the Essex-Company Contribution Agreement on the date hereof shall be as set forth on Annex F. On the date
hereof, S&N shall provide on Annex E a  

  
 30 








 
good faith estimate of the allocation of federal income tax basis and value of each asset it contributed pursuant to the S&N-Company Contribution Agreement on the date hereof, and within
90 Business Days after the date hereof, S&N and the Essex Members shall agree to and finalize the allocation of federal income tax basis and value of each asset. On the date hereof, the Essex Members shall provide on Annex F a good faith
estimate of the allocation of federal income tax basis and value of each asset it contributed pursuant to the Essex-Company Contribution Agreement on the date hereof, and within 90 Business Days after the date hereof, S&N and the Essex Members
shall agree to and finalize the allocation of federal income tax basis and value of each asset. Unless otherwise required by a “determination” (within the meaning of Section 1313(a) of the Code), S&N, the Essex Members, the
Tax Matters Member, the Company and its Subsidiaries shall not take any position inconsistent with Annex E or Annex F or the final federal income tax basis without the prior affirmative vote or unanimous written consent of all of the
Investors. In the event that any of the allocations described in this Section 6.04(g)(ii) are disputed by any taxing authority, the party receiving notice of such dispute shall promptly notify and consult with the Company and the other party
concerning the resolution of such dispute. 
 ARTICLE 7 

INDEMNIFICATION 

Section 7.01 Indemnification. The Company will indemnify as set forth below any Member or person who serves
as an officer, Manager or employee of the Company (each, a “Company Party”) in connection with any action, suit or proceeding, whether civil, criminal, administrative or investigative (a “Proceeding”) relating to
such Company Party’s status as a Member or service as an officer, Manager or employee of the Company or (at the Company’s request) of another entity in which the Company or any of its Subsidiaries has an interest (such Company Party’s
“Indemnified Service”): 
 (a) The Company shall indemnify and hold harmless the Company Party, to the fullest extent
permitted by Applicable Law, against all liability and loss suffered and expenses (including attorneys’ fees) actually and reasonably incurred by the Company Party in connection with any Proceeding in which the Company Party is made or is
threatened to be made a party by reason of the Company Party’s Indemnified Service. 
 (b) The Company Party must give notice
promptly to the Company’s chief legal officer or company secretary (provided that if no such position exists, the Company shall designate a responsible officer for purposes of this Section) of any Proceeding for which indemnity may be
sought hereunder. The Company shall have the right to select counsel to represent the Company Party at the Company’s expense and to control the defense and disposition of such Proceeding for so long as the Company expects to provide indemnity
with regard to such Proceeding. If such counsel determines that a conflict of interest exists between the Company and the Company Party, then the Company Party may retain separate counsel at the Company’s expense to participate in the
Proceeding to the extent necessary to protect Company Party’s interest; provided that the Company shall not be obliged to pay for more than one separate counsel for all Company Parties in connection with any one Proceeding. In addition,
the Company Party may, at any time, retain separate counsel at the Company Party’s expense to participate in the Proceeding. 

  
 31 








 (c) Notwithstanding the foregoing, the Company Party shall not be entitled to indemnity from the
Company under this Section 7.01 or otherwise in connection with (x) a Proceeding (or part thereof) commenced by the Company Party, unless such commencement was authorized by the Board of Managers, (y) a Proceeding commenced by the
Company or any of its Subsidiaries against the Company Party, or (z) a Proceeding that is based upon, results from, or relates to: 

(i) any acts or omissions by the Company Party occurring prior to commencement, or after termination, of the Indemnified
Service; 
 (ii) any willful misconduct, bad faith or active and deliberate dishonesty by the Company Party, or acts or
omissions by which the Company Party personally gained in fact a financial profit or other advantage to which the Company Party was not legally entitled; 

(iii) any acts or omissions of the Company Party that were outside the scope of the Indemnified Service; or 

(iv) any violation by the Company Party of the Company’s Code of Conduct and Business Principles (or equivalent policy) or
similar integrity policy of the Company or any of its Subsidiaries. 
 (d) To the extent permitted under Applicable Law, the Company shall
advance to the Company Party expenses (including attorneys’ fees) in connection with a Proceeding for which indemnity is sought under this Section 7.01; provided, however, that (i) such advances shall be made only upon prior receipt
of an undertaking by the Company Party to repay immediately all amounts advanced if it is ultimately determined that such Company Party was not entitled to indemnification under this Section 7.01 and (ii) the Company may decline to advance
expenses if the Board of Managers reasonably determines in good faith at any time that it is likely that the Company Party will not be entitled to indemnification under this Section 7.01. 

(e) The Company’s obligation to indemnify or to advance expenses to the Company Party shall be reduced by any amount the Company Party
collects as indemnification or advancement of expenses from any other source, including the entity served and its insurer. The Company Party will take such action as the Company may reasonably request to collect, or enable the Company to collect,
from such other sources. 
 Section 7.02 Standard of Care; Elimination of Fiduciary Duties. (a) To the extent that any
Company Party is performing duties on behalf of the Company, each such Company Party is to perform such duties in good faith and within the scope of authority conferred upon such Company Party. 

  
 32 








 (b) Each Company Party, in the performance of his or her duties, is entitled to rely in good
faith on information, opinions, reports or other statements, including financial statements, books of account and other financial data, if prepared or presented by: (i) one or more other Company Parties, if the Person relying on the statements
reasonably believes that the Person preparing or presenting the material is reliable and competent in that matter; or (ii) legal counsel, public accountants or other Persons, as to matters that the Person relying on the statements reasonably
believes are within the Person’s professional or expert competence. 
 (c) Without limiting any other provision hereof (including,
without limitation, Section 9.13), pursuant to Section 18-1101 of the Delaware Limited Liability Company Act, any fiduciary duties of any Investor or any Profits Interest Member (but, in the case of any Profits Interest Member, solely in
his or her capacity as a Member hereunder, and not in any other capacity, whether as a Manager, officer, director or employee of the Company) to the Company or to any other Member that would otherwise apply at law or in equity are hereby eliminated
to the fullest extent permitted under Delaware Law and any other Applicable Law; provided that the foregoing will not (i) eliminate the obligation of each Member to act in compliance with the express terms of this Agreement (including, without
limitation, Section 9.13), (ii) be deemed to eliminate the implied contractual covenant of good faith and fair dealing and (iii) apply in the case of gross negligence or willful misconduct. 

Section 7.03 Insurance. The Company may purchase and maintain insurance on behalf of any person who is or was a Manager, officer,
director, employee or agent of the Company or any of its Subsidiaries, or is or was serving at the request of the Company or any of its Subsidiaries as a Manager, officer, director, employee or agent of another corporation, partnership, joint
venture, limited liability company, trust or other enterprise against any expense, liability or loss incurred by such person in any such capacity or arising out of his or her status as such, whether or not the Company or any of its Subsidiaries
would have the power to indemnify such Person against such liability under Delaware Law; provided that, to the extent the Company purchases and maintains insurance on behalf of any Manager or director of the Company or any of its Subsidiaries, such
insurance shall cover all Managers or directors of the Company or the applicable Subsidiary on an equal and non-discriminatory basis. 

Section 7.04 Miscellaneous. (a) The rights and authority conferred in this Article 7 shall not be exclusive of any other
right which any person may otherwise have or hereafter acquire. 
 (b) Neither the amendment of this Article 7, nor, to the fullest extent
permitted by Delaware Law, any modification of law, shall eliminate or reduce the effect of this Article 7 in respect of any acts or omissions occurring prior to such amendment or modification. 

(c) No provision of this Article 7 shall limit or affect any Member’s obligation to comply with the express terms of this Agreement or the
Related Documents. 
 (d) This Article 7 shall not modify, alter or otherwise have any effect on any indemnification rights of any Person
pursuant to the Related Documents. 

  
 33 








 ARTICLE 8 

TRANSFER OF INTERESTS 

Section 8.01 General Restrictions. (a) No Transfer of any or all Units may be made by any Member or its Affiliates (and each
Member shall ensure that no Transfer by it or any of its Affiliates is made) except for Transfers (i) to Permitted Transferees (provided that any such Transfer is made in accordance with this Agreement and any applicable Award Agreement under
which the Transferor is bound), (ii) in accordance with Section 8.03 (Right of First Refusal), Section 8.04 (Right of First Offer), Section 8.05 (Tag-Along Rights), Section 8.06 (Drag-Along Sale), Section 9.04 (S&N
Rights of First Negotiation), and Section 9.06 (S&N Right to Compel an Exit), (iii) in a Public Offering, (iv) by any of the Essex Members or its Permitted Transferees (A) prior to the second anniversary of the date hereof
with the prior written consent of S&N or (B) in accordance with Section 8.09 (Essex Syndication Right), or (v) by S&N or its Permitted Transferees prior to the second anniversary of the date hereof with the prior written
consent of the Essex Members. Notwithstanding the first sentence of this Section 8.01(a), no Member may (1) pledge, encumber or hypothecate any of its Company Securities or (2) enter into any derivative, swap, participation or similar
arrangement that transfers, directly or indirectly, in whole or in part, any of the economic consequences of ownership of such Units. The restrictions set forth in this Section 8.01(a) shall terminate upon the consummation of a Qualified
Initial Public Offering or on such earlier date as is specified in this Section 8.01(a). 
 (b) Immediately prior to any Permitted Transferee
of any Member ceasing to be a Permitted Transferee thereof, such Permitted Transferee shall Transfer the Units then held by such Permitted Transferee to the Member from which it received such Units (or to another Permitted Transferee of such
Member), and such Transfer shall not be subject to the provisions of this Article 8. 
 (c) Any Transfer of Units which is not made in
compliance with the provisions of this Agreement, including Section 3.06 hereof, shall be void and no such Transfer shall be recognized on the books and records of the Company or any other Person. Notwithstanding anything else contained herein,
no Transfer shall be made except in compliance with the Securities Act. If reasonably requested by the Board of Managers, each Transferee Member agrees to pay, prior to or simultaneously with the time of the Transfer, all expenses, including
reasonable attorneys’ fees, incurred by the Company in connection with such Transfer. 
 (d) Notwithstanding anything to the contrary in
this Agreement, (i) Transfers of shares of Smith & Nephew plc or any successor thereof shall not be considered Transfers prohibited by this Section 8.01 and (ii) this Section 8.01 shall not be applicable in connection
with any Transfer by Smith & Nephew plc and its Subsidiaries, pursuant to a transaction or series of related transactions, of all or substantially all of the business of Smith & Nephew plc and its Subsidiaries (taken as a whole).

 (e) No Member may Transfer (i) any Common Units to any Transferee unless such Member simultaneously Transfers to the applicable
Transferee a number of OUS Units that represents the same proportion of the total number of OUS Units held by such Member and its Permitted Transferees as the number of Common Units being Transferred represents of the total number of Common Units
held by such Member and its Permitted Transferees, or (ii) any OUS Units to any Transferee unless such Member simultaneously Transfers to the applicable Transferee a number of Common Units that represents the same proportion of the total number
of Common Units held by such Member and its Permitted Transferees as the number of OUS Units being Transferred represents of the total number of OUS Units held by such Member and its Permitted Transferees. 

  
 34 








 (f) No Member Entity Transfer may be effected unless the applicable Member (i) does not own
any assets of any kind other than Units, (ii) does not have any liabilities of any kind, including Indebtedness, other than any liabilities associated with its ownership of Units or pursuant to the Transaction Documents and (iii) is an
entity organized under the laws of a jurisdiction within the United States. 
 Section 8.02 Transferee Rights. Any Person who is
a Transferee of any portion of a Member’s Units in accordance with this Agreement shall become a substitute Member; provided, however, that, in the event of any Member Entity Transfer, the applicable Member shall remain a Member, and the
applicable Transferee shall not become a substitute Member solely by reason of such Transfer. A Permitted Transferee of any Units or rights attributable to the Units of any Member shall be entitled to receive distributions of cash or other property
from the Company to the extent of the rights under such Units. 
 Section 8.03 Right of First Refusal.
(a) Subject to Section 8.08, if applicable, from and after the second anniversary of the date of this Agreement, if any Investor (the “Offering Member”) receives an unsolicited offer or proposal (whether or not binding)
from a third party and proposes to Transfer (in one transaction or in a series of transactions, including, for the avoidance of doubt, either directly or indirectly through a Member Entity Transfer) any Units to such third party (other than
(i) to a Permitted Transferee, (ii) in a Public Offering, (iii) in a sale pursuant to Section 8.05, (iv) in a Company Sale (except that any Company Sale by means of a Transfer of less than all of the Units then outstanding
shall be subject to this Section 8.03) or (v) in a Drag-Along Sale), the Offering Member shall give written notice (the “Offer Notice”) to (A) S&N, S&N Blocker (after S&N Blocker becomes a Member) and the
Permitted Transferees thereof (if any of the Essex Members or any Permitted Transferee thereof is the Offering Member) or (B) the Essex Members and the Permitted Transferees thereof (if S&N or any Permitted Transferee thereof is the
Offering Member) (S&N and S&N Blocker, on the one hand, or the Essex Members, on the other hand, the “Deciding Members”) and the Company of such proposal. The Offer Notice shall specify (1) the number of Units proposed
to be Transferred (in the case of a Member Entity Transfer, as determined in accordance with Section 8.08(a)(i)), (2) the proposed purchase price (which shall consist solely of cash consideration, and which shall be, in the case of a
Member Entity Transfer, the price at which the Offering Member proposes to Transfer the equity interests of the applicable Member pursuant to such Member Entity Transfer (the “Member Entity ROFR Price”)), (3) the identity of
the proposed third party Transferee and (4) the other material terms and conditions of the proposed Transfer, including any additional information with respect to the Transfer required to be included in the Offer Notice pursuant to
Section 8.03(e) and, with respect to Section 8.05 hereof, the number of Units eligible to be Transferred pursuant to Section 8.05 by the Members exercising their Tag Along Rights and the purchase price to be received with respect to
such Units. 
 (b) Each Deciding Member shall have the right and option (the “ROFR Right to Purchase”),
exercisable within 30 days after the date of the Offer Notice, to purchase up to its ROFR Percentage of the Units proposed to be Transferred at the price (which shall be in cash payable by wire transfer of immediately available funds in U.S.
Dollars) and on the terms and conditions set forth in the Offer Notice by providing written notice of that election to the Offering Member (and the other Investors). In the case of a proposed indirect Transfer of Units by the Offering Member through
a Member Entity Transfer subject to this Section 8.03(b), each  

  
 35 








 
Deciding Member shall have the further right and option, exercisable by inclusion of such Deciding Member’s election in the written notice referred to in the immediately preceding
sentence, to exercise its ROFR Right to Purchase with respect to either the Units held by the Offering Member (subject to Section 8.03(e)) or the equity interests of the Offering Member proposed to be Transferred pursuant to such Member Entity
Transfer. If any Deciding Member fails to elect to purchase its ROFR Percentage of the Units within such 30-day period, the Offering Member shall give prompt written notice of such failure to those other Deciding Members (if any) who do offer to
purchase up to their ROFR Percentage pursuant to the ROFR Right to Purchase and such other Deciding Members may purchase on apro rata basis, based on the number of Units they have previously elected to purchase, all of the balance thereof (or commit
to purchase all of the balance thereof) at the price and on the terms and conditions set forth in the Offer Notice by providing written notice of that election to the Offering Member within 10 days after the expiration of the 30-day period described
above (such 30-day period, as may be extended by the additional 10-day period, the “ROFR Period”). Any offer to purchase Units pursuant to the ROFR Right to Purchase shall be irrevocable and binding on the Deciding Member making
such offer, subject only to compliance by the Offering Member with the terms of this Section 8.03. The failure of any Deciding Member to advise the Offering Member of such Deciding Member’s decision to purchase Units within the applicable
periods described above shall be deemed to constitute a notification to the Offering Member of a decision not to exercise the ROFR Right to Purchase. 

(c) The closing for all Transfers of the Units purchased pursuant to the exercise of the ROFR Right to Purchase shall occur within 30 days
after the expiration of the ROFR Period (which 30-day period shall be extended to up to 90 days in the event any required approval of such sales from any governmental entity, including termination or expiration of the applicable waiting period under
the HSR Act, has not then been obtained), or at such other time as may be mutually agreed upon by the Offering Member and the applicable Deciding Members purchasing the Units, with the Offering Member being required to provide representations and
indemnification to such purchasers only with respect to due authorization, valid execution and delivery, good title to the Units and no Liens on such Units (except as may arise under the terms of this Agreement). If any purchasing Deciding Member
shall default in its obligations to purchase Units pursuant to this Section 8.03(c), the other purchasing Deciding Members shall be entitled to purchase the Units that such defaulting Deciding Member failed to purchase on the same basis as the
other Units purchased by the non-defaulting Deciding Members; provided that such purchase shall take place within 10 Business Days of such default. 

(d) Upon the failure of (i) the Deciding Members to exercise their Rights to Purchase with respect to all (and not less than all)
of the Units subject to an Offer Notice in accordance with Section 8.03(b) or (ii) the purchasing Deciding Members to purchase all (and not less than all) of the Units subject to such Offer Notice pursuant to Section 8.03(c) within
the time designated therein for closing, as applicable (the time of such applicable failure, the “ROFR Termination”), the Offering Member shall be relieved of such Offering Member’s obligations under this Section 8.03 with
respect to that particular proposed Transfer and, subject to Section 8.05, such Offering Member shall be permitted, for a 90-day period commencing upon the ROFR Termination (which 90-day period shall be extended up to 180 days in the event any
required approval of such sales from any governmental entity, including termination or expiration of the applicable waiting period under the HSR Act, has not then been obtained), to  

  
 36 








 
Transfer the Units subject to the Offer Notice to the third party(s) set forth in the Offer Notice at a price not lower, and on other terms and conditions in the aggregate not significantly more
favorable to the third party(s), than offered to the Deciding Members in the Offer Notice. If, at the end of such 90-day (or up to 180-day, as applicable) period, the Offering Member has not completed such Transfer to such third party(s), then all
the restrictions on Transfer contained in this Agreement with respect to Units subject to such Offer Notice shall again be in effect. 

(e) Notwithstanding any other provision of this Section 8.03 to the contrary, in connection with any proposed indirect Transfer of
Units through a Member Entity Transfer subject to this Section 8.03, if any Deciding Member exercises its ROFR Right to Purchase with respect to the Units held by the Offering Member, rather than with respect to the equity interests of the
Offering Member proposed to be Transferred pursuant to such Member Entity Transfer, such Deciding Member agrees that the price that it shall pay to the Offering Member for such Units in connection with the exercise of its ROFR Right to Purchase (the
“Member Unit ROFR Price”) shall be equal to (i) the Member Entity ROFR Price plus (ii) an amount equal to the product of 
  





 
 For purpose of this Section 8.03(e), the Offering Member’s “Gain” equals the excess, if
any, of the Member Entity ROFR Price over the Offering Member’s basis in its Units for U.S. federal income tax purposes, and “T” equals the Assumed Tax Rate. In connection with any proposed indirect Transfer of Units through a
Member Entity Transfer subject to this Section 8.03, the Offering Member shall include the Member Unit ROFR Price and shall certify its basis in the relevant Units for U.S. federal income tax purposes in the Offer Notice. 

(f) This Section 8.03 shall terminate upon the consummation of a Qualified Initial Public Offering. 

Section 8.04 Right of First Offer. (a) Subject to Section 8.08, if applicable, from and after the
second anniversary of the date of this Agreement, if any Investor (the “Transferring Member”) proposes to Transfer (in one transaction or in a series of transactions, including, for the avoidance of doubt, either directly or
indirectly through a Member Entity Transfer) any Units to a third party (other than (i) to a Permitted Transferee, (ii) in a Public Offering, (iii) in a sale pursuant to Section 8.05, (iv) in a Company Sale (except that any
Company Sale by means of a Transfer of less than all of the Units then outstanding shall be subject to this Section 8.04), (v) in a Drag-Along Sale or (vi) in a sale pursuant to Section 8.03), the Transferring Member shall give
written notice (the “ROFO Notice”) to (A) S&N, S&N Blocker (after S&N Blocker becomes a Member) and the Permitted Transferees thereof (if any of the Essex Members or any Permitted Transferee thereof is the
Transferring Member) or (B) the Essex Members and the Permitted Transferees thereof (if S&N, S&N Blocker or any Permitted Transferee thereof is the Transferring Member) (S&N and S&N Blocker, on the one hand, or the Essex
Members, on the other hand, the “Electing Members”) and the Company of such proposed Transfer and the number of Units proposed to be Transferred pursuant thereto (in the case of a Member Entity Transfer, as determined in accordance
with Section 8.08(a)(i)). 

  
 37 








 (b) The Electing Members shall have the right and option, exercisable within 30 days after
the date of the ROFO Notice, to make an offer (the “Offer”) to purchase up to their respective ROFO Percentages of the Units proposed to be Transferred at a price proposed by the Electing Members (which shall be in cash payable by
wire transfer of immediately available funds in U.S. Dollars) (the “Member Entity ROFO Price”) and on the terms and conditions proposed by the Electing Members by providing written notice of the Offer to the Transferring Member (and
the other Investors). In the case of a proposed indirect Transfer of Units by the Transferring Member through a Member Entity Transfer subject to this Section 8.04(b), each Electing Member shall have the further right and option, exercisable by
inclusion of such Electing Member’s election in the written notice referred to in the immediately preceding sentence, to exercise its right to make an Offer with respect to either the Units held by the Transferring Member (subject to
Section 8.04(e)) or the equity interests of the Transferring Member proposed to be Transferred pursuant to such Member Entity Transfer. If any Electing Member fails to make an Offer to purchase its ROFO Percentage of the Units within such
30-day period, the Transferring Member shall give prompt written notice of such failure to those other Electing Members (if any) who do make an Offer to purchase up to their ROFO Percentage and such other Electing Members may make an Offer to
purchase on a pro rata basis, based on the number of Units they have previously offered to purchase, all of the balance thereof (or commit to purchase all of the balance thereof) at the price and on the terms and conditions proposed by such Electing
Member by providing written notice of that proposal to the Transferring Member within 10 days after the expiration of the 30-day period described above (such 30-day period, as may be extended by the additional 10-day period, the “ROFO
Period”). Within 30 days after the end of the ROFO Period, the Transferring Member shall provide written notice (the “ROFO Response Notice”) to any Electing Member that has made an Offer prior to the end of the ROFO Period
as to whether the Transferring Member accepts or rejects such Electing Member’s Offer, and the Transferring Member shall be deemed to have rejected the Offer of any Electing Member if it fails to so notify such Electing Member. Any Offer made
by any Electing Member pursuant to this Section 8.04(b) shall be irrevocable and binding on the Electing Member making such Offer, subject only to compliance by the Transferring Member with the terms of this Section 8.04. 

(c) The closing for all Transfers of the Units purchased by the Electing Members pursuant to the Transferring Member’s acceptance of any
Offer shall occur within 30 days after the expiration of the ROFO Period (which 30-day period shall be extended to up to 90 days in the event any required approval of such sales from any governmental entity, including termination or expiration of
the applicable waiting period under the HSR Act, has not then been obtained), or at such other time as may be mutually agreed upon by the Transferring Member and the applicable Electing Members purchasing the Units, with the Transferring Member
being required to provide representations and indemnification to such purchasers only with respect to due authorization, valid execution and delivery, good title to the Units and no Liens on such Units (except as may arise under the terms of this
Agreement). If any purchasing Electing Member shall default in its obligations to purchase Units pursuant to this Section 8.04(c), the other purchasing Electing Members shall be entitled to purchase the Units that such defaulting Electing
Member failed to purchase on the same basis as the other Units purchased by the non-defaulting Electing Members; provided that such purchase shall take place within 10 Business Days of such default. 

  
 38 








 (d) Upon the failure of (i) the Electing Members to exercise their right to make an
Offer with respect to all (and not less than all) of the Units subject to a ROFO Notice in accordance with Section 8.04(b) or (ii) the purchasing Electing Members to purchase all (and not less than all) of the Units subject to such ROFO
Notice pursuant to Section 8.04(c) within the time designated therein for closing, as applicable (the time of such applicable failure, the “ROFO Termination”), the Transferring Member shall be relieved of such Transferring
Member’s obligations under this Section 8.04 with respect to that particular proposed Transfer and, subject to Section 8.05, such Transferring Member shall be permitted, for a 90-day period commencing upon the ROFO Termination (which
90-day period shall be extended up to 180 days in the event any required approval of such sales from any governmental entity, including termination or expiration of the applicable waiting period under the HSR Act, has not then been obtained), to
Transfer the Units subject to the ROFO Notice to one or more third party(s) at a price not lower, and on other terms and conditions in the aggregate not significantly more favorable to the third party(s), than offered to the Transferring Member by
the Electing Members. If, at the end of such 90-day (or up to 180-day, as applicable) period, the Transferring Member has not completed such Transfer to one or more third party(s), then all the restrictions on Transfer contained in this Agreement
with respect to Units subject to such ROFO Notice shall again be in effect. 
 (e) Notwithstanding any other provision of this
Section 8.04 to the contrary, in connection with any proposed indirect Transfer of Units through a Member Entity Transfer subject to this Section 8.04, if any Electing Member makes an Offer with respect to the Units held by the
Transferring Member, rather than with respect to the equity interests of the Transferring Member proposed to be Transferred pursuant to such Member Entity Transfer, such Electing Member agrees that the price that it shall pay to such Transferring
Member for such Units (the “Member Unit ROFO Price”) shall be equal to (i) the Member Entity ROFO Price plus (ii) an amount equal to the product of: 

 
 



 
 For purpose of this Section 8.04(e), the Transferring Member’s “Gain” equals the excess,
if any, of the Member Entity ROFO Price over the Transferring Member’s basis in its Units for U.S. federal income tax purposes, and “T” equals the Assumed Tax Rate. In connection with any proposed indirect Transfer of Units
through a Member Entity Transfer subject to this Section 8.04, the Transferring Member shall include the Member Unit ROFO Price and shall certify its basis in the relevant Units for U.S. federal income tax purposes in the ROFO Response
Notice. 
 (f) This Section 8.04 shall terminate upon the consummation of a Qualified Initial Public Offering. 

Section 8.05 Tag-Along Rights. (a) Subject to Sections 8.07 and, if applicable, 8.08, at any time
following a ROFR Termination pursuant to Section 8.03(d) or a ROFO Termination pursuant to Section 8.04(d), if the Essex Members or any of their Permitted Transferees (the “Essex Offering Members”) propose to Transfer (in
one transaction or in a series of transactions, including, for the avoidance of doubt, a Member Entity Transfer) any Units (other than (i) to a Permitted Transferee, (ii) in a Public Offering or (iii) in a sale pursuant to Section 


  
 39 








 
8.06) to a third party Transferee (a “Tag-Along Sale”), such Essex Offering Members shall provide each Investor (other than the Essex Offering Members and their Permitted
Transferees) and, in the case that the proposed Tag-Along Sale would constitute a Transfer of Units representing a Percentage Interest of more than 66.66% (such Transfer, a “PIM Tag-Along Trigger Event”) if effectuated, each Profits
Interest Member, written notice (the “Tag-Along Notice”) of the terms and conditions of such proposed Transfer (which terms and conditions, including price, shall comply with the provisions of Section 8.03(d) or
Section 8.04(d), as applicable), and each such Investor and, in the case of a Profits Interest Member Tag-Along Trigger Event, each such Profits Interest Member, shall have the opportunity to participate in such Transfer in accordance with this
Section 8.05. 
 (b) Each Investor (other than the Essex Offering Members and their Permitted Transferees), and in the case
that the proposed Tag-Along Sale would constitute a PIM Tag-Along Trigger Event if effectuated, each Profits Interest Member, shall have the right (a “Tag-Along Right”), exercisable by written notice (a “Tag-Along Response
Notice”) given to the Essex Offering Members within 10 Business Days following its receipt of the Tag-Along Notice (the “Tag-Along Right Period”), to require the Essex Offering Members to include in the proposed Transfer up
to a number of Units representing such Member’s Tag-Along Portion (each such exercising Member, a “Tagging Member”); provided that (i) notwithstanding anything else contained herein to the contrary, no Profits Interest
Member shall have the right to Transfer any unvested Profits Interest Units pursuant to this Section 8.05 and (ii) in the case of a proposed indirect Transfer of Units through a Member Entity Transfer subject to this Section 8.05(b),
S&N Blocker (after S&N Blocker becomes a Member) and its Permitted Transferees shall have the right, exercisable by inclusion of its election in the Tag-Along Response Notice, to require the Essex Offering Members to include in the proposed
Transfer the equity interests of S&N Blocker or such Peunitted Transferee in lieu of the Units held by S&N Blocker or such Permitted Transferee; and provided, further, that the Essex Offering Members shall be entitled to include the number
of Units proposed to be Transferred by the Essex Offering Members as set forth in the Tag-Along Notice (reduced, to the extent necessary, so that each Tagging Member shall be able to include its Tag-Along Portion) and such additional Units as
permitted by Section 8.05(c). If any Member has not exercised its Tag-Along Right in full prior to the expiration of the Tag-Along Right Period, such Member shall be deemed to have waived its Tag-Along Right with respect to the remaining
portion of its Tag-Along Portion in connection with the Transfer of Units described in the Tag-Along Notice. Each Tag-Along Response Notice shall include wire transfer or other instructions for payment of any consideration for the Units being
transferred in the Tag-Along Sale. Delivery of a Tag-Along Response Notice shall constitute an irrevocable exercise by such Tagging Member of its Tag-Along Right with respect to the number of Units specified in such Tag-Along Response Notice,
subject to the provisions of this Section 8.05 and Sections 8.07 and, if applicable, 8.08. 
 (c) If (i) any Member declines
to exercise its Tag-Along Right or (ii) any Tagging Member elects to exercise its Tag-Along Right with respect to less than such Tagging Member’s full Tag-Along Portion, the Essex Offering Members shall be entitled to Transfer in the
Tag-Along Sale a number of Units held by them equal to the number of Units in respect of which Tag-Along Rights were not exercised, at a price not higher, and on other terms and conditions in the aggregate not significantly more favorable to the
Essex Offering Members, than offered to the Investors in the Tag-Along Notice. 

  
 40 








 (d) The Essex Offering Members will use commercially reasonable efforts to obtain the agreement
of the prospective Transferee to the participation of the Tagging Members in any contemplated Transfer, and the Essex Offering Members will not effect any Transfer of any of its Units to the prospective Transferee unless, simultaneously with such
Transfer, the prospective Transferee purchases from each Tagging Member the Units which such Tagging Member is entitled to and elects to sell to such prospective Transferee pursuant to this Section 8.05. 

(e) The purchase from the Members exercising Tag-Along Rights pursuant to this Section 8.05 shall be on the same terms and conditions,
including any representations, warranties, covenants, indemnities and form of consideration, and on the same date of Transfer, as are received by the Essex Offering Members and stated in the Tag-Along Notice, and shall be subject to Sections 8.07
and, if applicable, 8.08; provided that the consideration from such sale shall be allocated among the Members (or their direct or indirect owners, in the case of a Member Entity Transfer) at the same price per Unit, except in the case of a Tag-Along
Sale involving (i) a Transfer of all outstanding Units (determined without regard to the EPR Unit) or (ii) a Transfer of Profits Interest Units (other than a Tag-Along Sale described in Section 8.05(e)(i)), in which case the
consideration from such sale shall be allocated among the Members (or their direct or indirect owners, in the case of a Member Entity Transfer) pursuant to the provisions of Sections 10.05 and 10.06 (taking into account the applicable Benchmark
Amount of each Profits Interest Unit so Transferred); provided, further, that in the case of any Tag-Along Sale described in Section 8.05(e)(ii), (1) for the avoidance of doubt, the holders of the Profits Interest Units so Transferred
shall not receive any portion of the consideration from such sale unless and until each of the holders of outstanding Preferred Units and former holders of Preferred Units previously Transferred pursuant to a Preferred Transfer Event and the holders
of outstanding Common Units, OUS Units and the EPR Unit have received consideration from such sale in respect of such Units equal to the aggregate amount that each such holder or former holder is entitled to receive with respect to such Units
pursuant to Sections 10.05(a)(i) through 10.05(a)(iv); and (2) any Profits Interest Units so Transferred shall be cancelled upon the consummation of such Tag-Along Sale, may not be reissued at any time thereafter and shall not be entitled to
any future distributions whatsoever pursuant to this Agreement. Promptly after the consummation of the Tag-Along Sale (but in no event later than two Business Days thereafter), the Essex Offering Members shall (B) notify the Tagging Members
thereof, (C) remit to the Tagging Members the total consideration for the Units of the Tagging Members Transferred pursuant thereto less the Tagging Members’ pro rata share of any applicable escrows, holdbacks or adjustments in purchase
price and any transaction expenses as determined in accordance with Sections 8.07 and, if applicable, 8.08, with the cash portion of the purchase price paid by wire transfer of immediately available funds in accordance with the wire transfer
instructions in the applicable Tag-Along Response Notices and (D) furnish such other evidence of the completion and the date of completion of such transfer and the terms thereof as may be reasonably requested by the Tagging Members. The Essex
Offering Members shall promptly remit to the Tagging Members any additional consideration payable to the Tagging Members upon the release of any escrows, holdbacks or adjustments in purchase price. No Tagging Members shall be required, for the
purpose of exercising its Tag-Along Right under this Section 8.05, to comply with the provisions of Section 8.03 or Section 8.04, as applicable, in connection with such Transfer. 

  
 41 








 (f) If at the end of the 90-day period commencing upon the expiration of the Tag-Along Right
Period (which 90-day period shall be extended up to 180 days in the event any required approval of such sales from any governmental entity, including termination or expiration of the applicable waiting period under the HSR Act, has not then been
obtained), the Essex Offering Members have not completed the Transfer of all the Units proposed to be sold by the Essex Offering Members and all Tagging Members on the terms and conditions set forth in the Tag-Along Notice, all the restrictions on
Transfer contained in this Agreement with respect to Units owned by the Essex Offering Members shall again be in effect. 
 (g)
Notwithstanding anything to the contrary contained in this Section 8.05, there shall be no liability on the part of the Essex Offering Members to any Member in the event that the Transfer of Units to the Person contemplated pursuant to this
Section 8.05 is not completed for any reason whatsoever, provided that the Essex Offering Members comply with all of the provisions of Section 8.03, Section 8.04, this Section 8.05, and Sections 8.07 and, if applicable, 8.08.

 (h) This Section 8.05 shall terminate upon the consummation of a Qualified Initial Public Offering. 

Section 8.06 Drag-Along Sale. (a) Subject to Sections 8.07, 9.01 and, if applicable, 8.08, if at
any time after the second anniversary of the date of this Agreement, (i) the Essex Members and their Permitted Transferees (the “Initiating Members”) propose to Transfer (in one transaction or in a series of transactions,
including, for the avoidance of doubt, a Member Entity Transfer) all of their Units (the “Essex Units”) to a third party that is not a Permitted Transferee of any of such Essex Members (such Transfer, a “Drag-Along
Sale” and such Transferee, the “Drag-Along Transferee”) and (ii) the Percentage Interest of the Essex Members and their Permitted Transferees at such time is, in the aggregate, greater than or equal to 51%, then the
Initiating Members may elect, subject to the provisions of this Section 8.06, to require each other Member (the “Other Members”) to Transfer in the Drag-Along Sale all of the Units then held by such Other Members for the
consideration and on the terms and conditions described in the Drag-Along Sale Notice, and each Other Member will be deemed to have consented to (and agrees to waive any dissenter’s rights, appraisal rights or similar rights in connection with)
such Drag-Along Sale and agrees to take all necessary action to transfer such Other Member’s Units on the terms and conditions specified in the Drag-Along Sale Notice; provided, however, that, notwithstanding anything to the contrary contained
herein, at the election of S&N Blocker (after S&N Blocker becomes a Member) or any Permitted Transferee thereof, any Drag-Along Sale shall be structured to permit any Transfer of Units by S&N Blocker or such Permitted Transferee pursuant
to such Drag-Along Sale to be effected indirectly pursuant to the Transfer of the equity interests of S&N Blocker or such Permitted Transferee. 

(b) If the Initiating Members elect to exercise their rights pursuant to Section 8.06(a), the Initiating Members shall provide
written notice of such Drag-Along Sale to the Other Members (a “Drag-Along Sale Notice”) specifying the purchase price (the “Drag-Along Sale Price”) that the Initiating Members propose be paid by the Drag-Along
Transferee and the other material terms and conditions of the proposed Transfer. 
 (c) In connection with any Drag-Along Sale,
(i) each Member (or its direct or indirect owners, in the case of a Member Entity Transfer) shall be entitled to receive the same form of consideration paid by the Drag-Along Transferee, (ii) if any Members (or their direct or indirect


  
 42 








 
owners, in the case of a Member Entity Transfer) are given an option as to the form of consideration to be received, all Members (or their direct or indirect owners, in the case of a Member
Entity Transfer) will be given the same option, and (iii) the aggregate consideration from such Drag-Along Sale shall be allocated among the Members (or their direct or indirect owners, in the case of a Member Entity Transfer) as provided in
Sections 10.05 and 10.06. 
 (d) The Initiating Members shall be permitted, for a 120-day period commencing upon the delivery of the
Drag-Along Sale Notice (which 120-day period shall be extended up to 180 days in the event any required approval from any governmental entity, including termination or expiration of the applicable waiting period under the HSR Act, has not then been
obtained), to effect a Drag-Along Sale at a price not lower, and on terms and conditions in the aggregate no more favorable to the Drag-Along Transferee(s), than described to the Other Members in the Drag-Along Sale Notice. If, at the end of such
120-day (or up to 180-day, as applicable) period, a Drag-Along Sale has not been consummated, then all the restrictions on Transfer contained in this Agreement shall again be in effect. 

(e) If the Initiating Members shall effect a Drag-Along Sale in accordance with Section 8.06(d), each Other Member shall be required to
participate in the Drag-Along Sale on the terms and conditions set forth in the Drag-Along Notice (which terms and conditions will also apply to the Initiating Members) and to tender all of its Units as set forth below. Not later than 10 days prior
to the consummation of Drag-Along Sale, each of the Other Members shall deliver to a representative of the Initiating Members designated in the Drag-Along Sale Notice wire transfer instructions for payment of the consideration to be received in such
Drag-Along Sale and an unconditional agreement to allow the Company to cause the books and records of the Company to show that such Units are bound by the provisions of this Section 8.06(e) and that such Other Member’s Units shall be
transferred to the Drag-Along Transferee concurrently with the consummation of the Drag-Along Sale and the delivery of the consideration therefor to such Other Member (or, if such Other Member refuses to accept delivery of such consideration,
deposit of such consideration with a third party escrow agent reasonably acceptable to the Company). 
 (f) If the Drag-Along Sale shall not
have been consummated during the period provided in Section 8.06(d), (i) the Initiating Members shall return to each of the Other Members any documents in the possession of the Initiating Members executed by the Other Members in connection
with such proposed Drag-Along Sale, (ii) the Company shall cause the books and records of the Company to show that the Units of the Other Members are no longer bound by the provisions of Section 8.06(e) with respect to the applicable
Drag-Along Sale and (iii) all the restrictions on Transfer contained in this Agreement or otherwise applicable at such time with respect to any Units shall again be in effect. 

(g) Concurrently with the consummation of the Drag-Along Sale pursuant to this Section 8.06, the Initiating Members shall give written
notice thereof to the Other Members, shall remit to each of the Other Members that have surrendered the applicable instruments, if any, the net consideration (payable by wire transfer in accordance with such Other Member’s wire transfer
instructions) for the Units Transferred pursuant hereto. 

  
 43 








 (h) Notwithstanding anything contained in this Section 8.06, there shall be no liability on
the part of the Initiating Members to the Other Members if the Drag-Along Sale is not consummated for whatever reason, regardless of whether the Initiating Members have delivered a Drag-Along Sale Notice. Whether to effect a Drag-Along Sale pursuant
to this Section 8.06 shall be in the sole and absolute discretion of the Initiating Members. 
 (i) This Section 8.06 shall
terminate upon the consummation of an Initial Public Offering. 
 Section 8.07 Additional Conditions to Tag-Along Sales and
Drag-Along Sales. (a) Each Member shall be obligated to pay only its pro rata share (based on the aggregate consideration received by such Member in respect of the Units Transferred by such Member) of expenses incurred in connection with a
consummated Tag-Along Sale or Drag-Along Sale to the extent such expenses are incurred for the benefit of all Members participating in such Tag-Along Sale or Drag-Along Sale and are not otherwise paid by the Company or another Person. 

(b) Subject to Section 8.08, if applicable, each Member shall (i) make such representations, warranties and covenants and enter into
such definitive agreements as are reasonably required in the proposed Transfer and as are customary for transactions of the nature of the proposed Transfer, provided that if the Members are required to provide any representations or indemnities in
connection with such Transfer, liability for misrepresentation or indemnity shall (as to such Members) be expressly stated to be several but not joint and each Member shall not be liable for more than its pro rata share (based on the aggregate
consideration received by such Member in respect of the Units Transferred by such Member) of any liability for misrepresentation or indemnity and (ii) be required to bear its pro rata share (based on the aggregate consideration received by such
Member in respect of the Units Transferred by such Member) of any escrows, holdbacks or adjustments in purchase price. 
 Section 8.08
Special Provisions for Member Entity Transfers. (a) Notwithstanding anything herein to the contrary, for purposes of Sections 8.03, 8.04, 8.05 and 8.06: 

(i) The number of Units Transferred pursuant to any Member Entity Transfer shall be deemed to be equal to (A) the number
of Units held by the applicable Member at the time of such Member Entity Transfer multiplied by (B) the percentage of the total issued and outstanding equity interests of such Member to be Transferred pursuant to such Member Entity Transfer;
and 
 (ii) The other terms and conditions of any Transfer of Units by any Deciding Member, Electing Member, Tagging Member,
Other Member pursuant to Section 8.03, 8.04, 8.05 or 8.06, as applicable, in connection with any Member Entity Transfer subject to such Section (including any representations, warranties, covenants or indemnities to be provided with respect
thereto) shall be substantially the same as the corresponding terms and conditions of such Member Entity Transfer, with only such differences therefrom as are necessary in light of the differences in the equity interests so Transferred. 

  
 44 








 (b) Notwithstanding anything herein to the contrary, for purposes of Sections 8.03, 8.04 and 8.05
(other than for purposes of allocating the consideration among the Members in connection with a Tag-Along Sale described in Section 8.05(e)(i) or (ii)), the purchase price per Unit Transferred pursuant to any Member Entity Transfer shall be
deemed to be equal to (i) the aggregate purchase price paid by the applicable Transferee for the equity interests of the applicable Member Transferred pursuant to such Member Entity Transfer, divided by (ii) the number of Units Transferred
pursuant to such Member Entity Transfer (as determined in accordance with Section 8.08(a)(i)). 
 (c) Notwithstanding anything herein to
the contrary, in the case of a Transfer by any Essex Member, S&N Blocker or any Permitted Transferee thereof otherwise permitted pursuant to this Agreement, such Transfer, at the election of such Investor or Permitted Transferee (but subject to
the applicable terms and conditions of this Agreement), shall be structured either as a direct transfer of Units held by such Essex Member, S&N Blocker or Permitted Transferee or a Member Entity Transfer by the owner(s) of such Essex Member,
S&N Blocker or Permitted Transferee. 
 Section 8.09 Essex Syndication Right. Until the six-month anniversary of the date of
this Agreement, any of the Essex Members may Transfer (in one or a series of transactions) up to 49% of the Units held by such Essex Member as of the date hereof to one or more third parties; provided that any such Transfer (a) shall be subject
to Section 3.06, (b) shall require the prior written approval of S&N (such approval not to be unreasonably withheld) and (c) shall not result in such Essex Member ceasing to be controlled by an Essex Fund or Essex, as applicable;
and provided, further, that, if an Essex Member Transfers any Units pursuant to this Section 8.09 for a price per Unit in excess of (i) the Initial Liquidation Preference plus (ii) the Accrued Preferred Distribution with respect to
such Unit, then such Essex Member shall pay S&N or its designee 49% of such excess with respect to all Units so Transferred promptly upon the consummation of such Transfer. Any Transferee of an Essex Member pursuant to this Section 8.09
shall be deemed to be a Permitted Transferee of such Essex Member for all purposes of this Agreement. 
 ARTICLE 9 

CERTAIN COVENANTS 

Section 9.01 S&N Right to Veto Sale. (a) Until the first anniversary of the date of this Agreement,
the Company shall not effect, and neither the Company, the Essex Members nor any of their respective Affiliates shall enter into, any agreement, arrangement or understanding (whether or not binding) with respect to a Company Sale without the prior
written consent of S&N (which may be withheld in S&N’s sole discretion). “Company Sale” means, directly or indirectly, including by means of a Drag-Along Sale, (i) the Transfer of all or substantially all of the
assets of the Company and its Subsidiaries to a Person or Persons other than S&N or any of its Affiliates, (ii) the merger of the Company or any of its Subsidiaries with a Person or Persons other than S&N or any of its Affiliates, which
results in such Person or Persons owning a majority of the equity of the surviving entity, or (iii) the Transfer of Units representing a Percentage Interest of more than 50%, or the Transfer of a controlling equity interest of the Company or
any of its Subsidiaries, to any Person or Persons other than S&N, an Essex Member or any of their respective Affiliates. 

  
 45 








 (b) Until the third anniversary of the date of this Agreement, the Company shall not
effect, and neither the Company, any Essex Member nor any of its Affiliates shall enter into, any agreement, arrangement or understanding (whether or not binding) with respect to a Competitor Sale without the prior written consent of S&N
(which may be withheld in S&N’s sole discretion). “Competitor Sale” means, directly or indirectly, (i) the Transfer of all or substantially all of the assets of the Company and its Subsidiaries to a Competitor,
(ii) the merger of the Company with a Competitor, or (iii) the Transfer of any Units held by an Essex Member or its Affiliates to a Competitor; and a Competitor Sale shall include any of the foregoing transactions in which a Competitor is
participating either alone or in combination with any other Competitor or third party. “Competitor” means any of Johnson & Johnson, Stryker Corporation, Zimmer Holdings, Inc., Medtronic, Inc., Synthes or Biomet, Inc.,
including, in each case, any Affiliates or successors of each such company, as well as any entity to which any such company transfers all or substantially all of those of its assets that compete with the Company or with S&N. 

Section 9.02 OUS Subsidiary Sale. Unless otherwise agreed by S&N and the Essex Members, other than in
connection with a Company Sale, the Company shall not effect, and neither the Company nor any of its Affiliates shall enter into any agreement, arrangement or understanding (whether or not binding) with respect to, an OUS Subsidiary Sale.
“OUS Subsidiary Sale” means, directly or indirectly, (i) the Transfer of all or substantially all of the assets of the OUS Subsidiary and its Subsidiaries, (ii) a merger, consolidation, reorganization, combination or other
similar transaction involving the OUS Subsidiary or any of its Subsidiaries, which results in a Person or Persons other than the Company owning a majority of the equity of the surviving entity, or (iii) the Transfer of a controlling equity
interest in the OUS Subsidiary. 
 Section 9.03 Company Sale Process. The Company and the Members agree that neither the
Company nor any of the Members may effect any Company Sale that is reasonably anticipated to result in aggregate consideration payable to the Investors pursuant to Section 10.05 that is less than the full amount of the distributions provided
for in Sections 10.05(a)(i) — 10.05(a)(iv) unless: 
 (a) the Company Sale is conducted pursuant to a customary business sale process
run by the Company and subject to the oversight of the Board of Managers with the assistance of a reputable nationally recognized independent financial advisor; 

(b) such business sale process results in a Company Sale at fair value, as reasonably determined by the Board of Managers with the assistance
of such financial advisor; 
 (c) S&N and its Affiliates are entitled to participate as a bidder in such business sale process on the
same terms and conditions applicable to other bidders invited to participate or participating in such process; and 
 (d) without limiting
the foregoing clauses (a) through (c), if such business sale process results in a Company Sale that would result in aggregate consideration payable to the Investors pursuant to Section 10.05 that is less than the full amount of the
distributions provided for in Sections 10.05(a)(i) — 10.05(a)(iv), then S&N, S&N Blocker (after S&N Blocker becomes a Member) and the Permitted Transferees thereof shall be entitled to purchase all (but not less than all) of the
Units of the other Members in lieu of the consummation of such Company Sale. The Company shall promptly provide written notice to S&N, S&N Blocker and the Permitted Transferees thereof of the identity of the proposed purchaser and the
material terms and conditions of the proposed sale. The provisions of Section 8.03 shall apply mutatis mutandis to S&N’s and S&N Blocker’s rights pursuant to this Section 9.03(d). 

  
 46 








 Section 9.04 S&N Rights of First Negotiation. (a) Until the third
anniversary of the date of this Agreement, so long as S&N’s Percentage Interest is greater than or equal to 15%, none of the Company, any Essex Member or any Affiliate of any Essex Member shall, directly or indirectly, solicit, negotiate,
encourage or otherwise discuss or agree with any Person (other than S&N and its Affiliates) or enter into any agreement, arrangement or understanding (whether or not binding) with respect to, a Company Sale or Qualified Initial Public Offering,
unless and until the Company (or the Essex Member or its Affiliates, as the case may be) has (i) notified S&N in writing of its desire to effect a Company Sale or Qualified Initial Public Offering, (ii) provided S&N with the
opportunity to negotiate with the Company (or the Essex Member or its Affiliates) on an exclusive basis for 60 days after the date of such notice regarding the acquisition by S&N of all or substantially all of the assets of the Company and its
Subsidiaries (or all or substantially all of the Units held by the Essex Members and their Permitted Transferees, whether by purchase of the Units, a Member Entity Transfer, merger or otherwise, as the case may be) (any such acquisition, an
“S&N Acquisition”) and (iii) if S&N elects to negotiate as set forth in the preceding clause (ii), to negotiate in good faith with S&N regarding an S&N Acquisition. 

(b) Until the earlier of (i) the seventh anniversary of the date of this Agreement, (ii) the first anniversary of the
consummation of a Company Sale and (iii) the six month anniversary of a Competitor Change of Control of S&N, the Company shall not, directly or indirectly, solicit, negotiate, encourage or otherwise discuss or agree with any Person (other
than S&N and its Affiliates) or enter into any agreement, arrangement or understanding (whether or not binding) with respect to, a New Product Partnership unless and until the Company has (A) notified S&N in writing of its desire to
enter into such New Product Partnership, (B) provided S&N with the opportunity to negotiate with the Company on an exclusive basis for 60 days after the date of such notice regarding the entry by S&N into such New Product Partnership
with the Company, and (C) if S&N elects to negotiate as set forth in the preceding clause (B), to negotiate in good faith with S&N regarding such New Product Partnership with S&N. “New Product Partnership” means an
agreement or other arrangement between the Company and one or more Persons regarding the development, manufacture, marketing or distribution of a new product. 

Section 9.05 Competitor Change of Control of S&N. Notwithstanding anything herein to the contrary, within
60 days of a Competitor Change of Control of S&N, the Essex Members may elect, by delivering notice of such election in writing to the Company and S&N, to terminate any or all of the rights of S&N set forth in Section 5.01(a)(ii),
Section 9.01, Section 9.04, Section 9.07, Section 9.12 and Annex A (provided that S&N shall at all times be entitled to receive such information relating to the Company and its Subsidiaries as is reasonably necessary for
S&N and its Affiliates to estimate and realize the value of, and account properly for, its investment and otherwise to comply with their obligations under Applicable Law, including compliance obligations). “Competitor Change of Control
of S&N” means the consummation of (a) a Transfer of all or substantially all of the assets or equity of Smith & Nephew plc and its Subsidiaries to a Competitor or (b) a merger of Smith & Nephew plc with a
Competitor. 

  
 47 








 Section 9.06 S&N Exit Right. (a) If an Exit has
not occurred prior to the seventh anniversary of the date of this Agreement, then, upon the written request of S&N at any time and from time to time thereafter (but not more frequently than once during any twelve-month period) until the
consummation of an Exit, the Company shall engage an investment bank or other financial advisor of nationally recognized reputation designated by the Board of Managers, subject to the consent of S&N, which shall not be unreasonably withheld,
conditioned or delayed, to serve as the Company’s financial advisor (the “Financial Advisor”). The Company shall instruct the Financial Advisor to commence an orderly process to result in an Exit with the objective of achieving
the highest practicable value for the Investors. The Company shall use its best efforts to reach agreement with the Investors on the optimal structure and the terms and conditions for the Exit and will retain independent legal counsel of appropriate
expertise. The fees and expenses of both the Financial Advisor and such legal counsel shall be borne by the Company. The Company shall require the Financial Advisor to keep each of S&N and Essex currently advised as to its efforts, any
expressions of interest or offers or proposals that are received and any other information relevant to the process conducted pursuant to this Section 9.06. 

(b) (i) The Company shall require the Financial Advisor to deliver to the Company, S&N and Essex written notice (the
“Recommended Exit Notice”) within 60 days of the engagement of the Financial Advisor that sets forth the Financial Advisor’s recommendation as to the Exit that will achieve the highest practicable value for the Investors (the
“Recommended Exit”); provided, however, that, notwithstanding anything to the contrary contained herein, at the election of any Essex Member, S&N Blocker (after S&N Blocker becomes a Member) or any Permitted Transferee
thereof, any Recommended Exit shall be structured to permit any Transfer of Units by such Investor pursuant to such Recommended Exit to be effected indirectly through a Member Entity Transfer. The Recommended Exit Notice shall include reasonably
detailed information with respect to the terms and conditions of the Recommended Exit (including with respect to structure, consideration and the identity of the parties involved) and, if applicable, the forms or current drafts of any proposed
definitive agreements with respect thereto. 
 (ii) If a Veto Party notifies the Company within 10 days of the
date of the Recommended Exit Notice (the “Recommended Exit Veto Period”) that it objects to the consummation of the Recommended Exit (a “Veto”), the Company shall not proceed with such Recommended Exit and shall
terminate the process related thereto; provided that, for the avoidance of doubt, notwithstanding any Veto by S&N pursuant to this Section 9.06(b)(ii)), the Essex Members and their Permitted Transferees may nevertheless exercise their
rights pursuant to Section 8.06 with respect to such Recommended Exit; and provided, further, that, notwithstanding any Veto by either Veto Party pursuant to this Section 9.06(b)(ii), this Section 9.06 shall continue to apply and be
available to S&N in accordance with its terms thereafter. 
 (iii) If no Veto Party has submitted a Veto
prior to the expiration of the Recommended Exit Veto Period in accordance with the terms of Section 9.06(b)(ii), then the Essex Members shall have the option (the “Essex Purchase Option”), in their sole discretion, in lieu of
the Company proceeding with the Recommended Exit, to purchase (the “Essex Purchase”) all (but not less than all) of the Units then held by S&N and its  

  
 48 








 
Permitted Transferees upon the terms and conditions set forth in this Section 9.06(b)(iii). The Essex Purchase Option shall be exercisable by the Essex Members upon written notice to
S&N within two days after the expiration of the Recommended Exit Veto Period (the “Essex Purchase Option Period”). Any Essex Purchase shall be (A) for an aggregate purchase price (which shall be in cash payable by wire
transfer of immediately available funds in U.S. Dollars) equal to the aggregate amount that S&N and its Permitted Transferees would have received upon the consummation of the applicable Recommended Exit pursuant to the terms hereof, including,
without limitation, Sections 10.05 and 10.06, and (B) on the other terms and conditions set forth in the Recommended Exit Notice, to the extent applicable, and otherwise on reasonable and customary terms and conditions for transactions of the
nature of the Essex Purchase, with S&N and its Permitted Transferees being required to provide representations and indemnification to the Essex Members only with respect to due authorization, valid execution and delivery, good title to the Units
and no Liens on such Units (except as may arise under the terms of this Agreement); provided that the closing of the Essex Purchase shall occur within 30 days after the expiration of the Essex Purchase Option Period (which 30-day period shall be
extended to up to 90 days in the event any required approval of such purchase from any Governmental Authority, including termination or expiration of the applicable waiting period under the HSR Act, has not then been obtained), or at such other time
as may be mutually agreed upon by S&N and the Essex Members. 
 (iv) If the Essex Members do not exercise the
Essex Purchase Option prior to the expiration of the Essex Purchase Option Period in accordance with the terms of Section 9.06(b)(iii), then the Company and each Member shall use their respective reasonable best efforts to consummate the
Recommended Exit as promptly as practicable on terms and conditions that in the aggregate are not less favorable to the Investors than those specified in the Recommended Exit Notice. 

(v) “Veto Party” means (A) prior to the eighth anniversary of the date of this Agreement, either
S&N or the Essex Members, and (B) thereafter, S&N only. 
 (c) Subject to the provisions of Section 9.06(b), each
Member shall, and, if applicable, shall use its reasonable best efforts to cause each Manager designated by such Member (such reasonable best efforts to include, to the extent necessary, removal or replacement of any such Manager) to, vote for,
execute any necessary consents in favor of, and enter into such definitive agreements as may be reasonably necessary or desirable for transactions of the nature of, the engagement of the Financial Advisor, the Recommended Exit and the Essex
Purchase, as applicable. The Company and each Member shall reasonably cooperate with the Financial Advisor in its efforts, and the Company shall prepare such documents and information as may reasonably be required in connection with the process
conducted, in each case pursuant to this Section 9.06. 

  
 49 








 Section 9.07 Information and Other Rights. (a) The Board of Managers shall
furnish to each Investor: 
 (i) As soon as practicable and, in any event, no later than six Business Days following the end
of each S&N Accounting Month, (A) the preliminary unaudited consolidated balance sheet of the Company and its Subsidiaries as at the end of such S&N Accounting Month, (B) the related preliminary unaudited statements of operations
and information pertaining to transactions between the Company and its Subsidiaries, on the one hand, and S&N and its Affiliates, on the other hand, for such S&N Accounting Month and for the portion of the Fiscal Year then ended, in the case
of each of clause (A) and (B), prepared in accordance with IFRS (or, if the Board of Managers has determined that the Company shall adopt and follow GAAP in lieu of IFRS pursuant to Section 6.01, prepared in accordance with GAAP), and
(C) a forecast of the Company’s performance for the remainder of the Fiscal Year relative to the Company’s annual operating budget for such Fiscal Year, and a forecast of the Company’s performance for the following Fiscal Year;

 (ii) As soon as practicable and, in any event, no later than six Business Days following the end of each S&N
Accounting Quarter (including, for the avoidance of doubt, the end of the Fiscal Year), (A) the preliminary unaudited consolidated balance sheet of the Company and its Subsidiaries as at the end of such S&N Accounting Quarter, (B) the
related preliminary unaudited statements of operations and information pertaining to transactions between the Company and its Subsidiaries, on the one hand, and S&N and its Affiliates, on the other hand, and S&N for such S&N Accounting
Quarter and for the portion of the Fiscal Year then ended, in the case of each of clause (A) and (B), prepared in accordance with IFRS (or, if the Board of Managers has determined that the Company shall adopt and follow GAAP in lieu of IFRS
pursuant to Section 6.01, prepared in accordance with GAAP, together with a reconciliation to IFRS), (C) a forecast of the Company’s performance for the remainder of the Fiscal Year relative to the Company’s annual operating
budget for such Fiscal Year and (D) a forecast of the Company’s performance for the following Fiscal Year; 
 (iii)
As soon as practicable and, in any event, within 30 days after the end of each fiscal month, the final management accounts for such fiscal month, which shall contain at a minimum (A) the unaudited statements of operations and cash flows for
such fiscal month and the portion of the Fiscal Year ended at the end of such fiscal month, in each case compared to the Company’s annual operating budget for such Fiscal Year, and (B) the unaudited consolidated balance sheet at the end of
such fiscal month, along with an ageing of trade receivables. 
 (iv) As soon as practicable and, in any event, within 75
days after the end of each Fiscal Year, (A) the audited consolidated balance sheet of the Company and its Subsidiaries as at the end of such Fiscal Year and the related audited statement of operations and cash flows for such Fiscal Year and the
related footnotes, in each case prepared in accordance with IFRS (or, if the Board of Managers has determined that the Company shall adopt and follow GAAP in lieu of IFRS pursuant to Section 6.01, prepared in accordance with GAAP, together with
a reconciliation to IFRS) and audited by the Company’s independent public accountants, (B) a comparison of the figures in the financial statements delivered pursuant to clause (A) with the figures for the previous Fiscal Year and the
figures in the Company’s annual operating budget and (C) any management letters or other correspondence from such accountants; 

  
 50 








 (v) As soon as practicable and, in any event, not less than 15 days prior to the
beginning of each Fiscal Year, the Company’s annual operating budget for such Fiscal Year; 
 (vi) Such information as
is provided to any lender or other financing source of the Company or any of its Subsidiaries; and 
 (vii) As promptly as
reasonably practicable, such other information with respect to the Company or any of its Subsidiaries as may reasonably be requested by such Investor. 

The financial statements and other information provided pursuant to Sections 9.07(a)(i)-9.07(a)(ii) shall be in a presentational format reasonably acceptable
to S&N. 
 (b) Subject to restrictions imposed by Applicable Law, any confidentiality or non-disclosure provision (in either case to the
extent relating to third party information) in any agreement to which the Company is a party and the obligations set forth in Section 9.10, the Investors will have, with respect to the Company and each Subsidiary of the Company, the right to:
(i) inspect properties, (ii) periodically consult with representatives of management and obtain information with respect to the business and affairs of the Company and its Subsidiaries (including without limitation with respect to
scientific, technical, clinical and other information relating to the Orthobiologics Field), (iii) consult with members of the Board of Managers and the board of directors or other governing bodies of the Subsidiaries or any committees thereof
with respect to all matters, (iv) inspect the books and records of the Company or any of its Subsidiaries and (v) perform audits to ensure that the Company has adequate procedures in place to comply with the matters set forth in
Section 9.14, subject, in each case, to the execution of a customary non-disclosure agreement and other reasonable safeguards to address conflicts of interests. 

Section 9.08 Maintenance and Inspection of Records. The accounting books and records, minutes of proceedings of the Board of
Managers and of the Members and all other information pertaining to the Company and its Subsidiaries that is required to be made available to the Members under Delaware Law shall be kept at such place or places designated by the Board of Managers or
in the absence of such designation, at the principal place of business of the Company, provided that a Profits Interest Member shall only be able to review and examine such information pertaining to the Company as required under Delaware Law and
redacted or aggregated as necessary to prevent disclosure of confidential information as may be determined by the Board of Managers from time to time. 

Section 9.09 Confidentiality. (a) During the term of this Agreement and thereafter, each party hereto
shall, and shall cause its Subsidiaries and controlled Affiliates to, maintain in confidence and use only for purposes of the business of the Company and its Subsidiaries, this Agreement and the Related Documents, all Confidential Information,
except to the extent that the Company and S&N agree otherwise with respect to particular Confidential Information in the possession of or furnished to S&N. “Confidential Information” means all information concerning the
Company or its Subsidiaries or the financial condition, business, operations or prospects of the Company or its Subsidiaries in the possession of or furnished to any Member  

  
 51 








 
(including by virtue of its present or former right to designate a Manager to the Board of Managers). Each party shall exercise the same care and safeguards with respect to Confidential
Information as is used to maintain the confidentiality of its own information of like character, but will, at a minimum, use reasonable care. 

(b) Any party may disclose Confidential Information to its Subsidiaries, Affiliates, directors, officers, employees, counsel, advisers,
consultants, outside contractors and other agents, on the condition that such Persons agree to keep the Confidential Information confidential to the same extent as such disclosing party is required to keep the Confidential Information confidential,
solely to the extent it is reasonably necessary or appropriate to fulfill its obligations or to exercise its rights under this Agreement or the Related Documents; provided that the disclosing party shall remain liable with respect to any breach of
this Section 9.09 by any such Subsidiaries, Affiliates, counsel, advisers, consultants, outside contractors and other agents. 
 (c)
Notwithstanding Section 9.09(a) or Section 9.09(b) above, a party may disclose such Confidential Information (i) to the extent that the such party is legally compelled (by oral questions, interrogatories, request for information or
documents, subpoena, civil investigative demand or similar process) to disclose any of the Confidential Information, (ii) for purposes of reporting to its stockholders the performance of the Company and its Subsidiaries and for purposes of
including applicable information in its financial statements to the extent required by Applicable Law or applicable accounting standards, (iii) to the extent required to be disclosed by Applicable Law, rule or regulation; provided that in
connection with any such disclosure, (A) a disclosing party shall only disclose such Confidential Information as is required to be disclosed in connection with the foregoing, (B) to the extent reasonably practicable, a disclosing party
shall provide the other party with prompt and advance written notice of any such intended disclosure so that such other party has a reasonable opportunity to limit such disclosure, or (if applicable, and to the extent reasonable practicable) seek a
protective order or other appropriate remedy to prevent such disclosure and (C) a disclosing party shall use its reasonable efforts to seek confidential treatment (consistent with the terms hereof) by the Person to whom such disclosure is made.
The parties acknowledge that money damages would not be a sufficient remedy for any breach of the provisions of this Section 9.09 and that the non-breaching party shall be entitled to equitable relief in a court of law in the event of, or to
prevent, a breach or threatened breach of this Section 9.09. 
 (d) The Essex Members represent and warrant to the other parties
hereto that the Essex Members are owned directly by the Essex Investors, which, in certain cases, are funds-of-funds (each, a “Fund”) that have certain reporting obligations to their respective investors and equity holders regarding
the nature and performance of their investment in the Company, and each Fund is managed or advised by such Fund’s general partner, investment manager, or Person serving in a similar capacity (each, a “Fund Manager”).
Notwithstanding anything to the contrary in this Section 9.09 or elsewhere in this Agreement, the parties hereto hereby acknowledge and agree that (i) each Essex Member may disclose Confidential Information to each Fund and its respective
Fund Managers and (ii) each Fund Manager and each Fund may disclose to its direct and indirect equity holders the following information: (A) the name and address of the Company, the year of its formation, and a brief description of its
strategy or focus, (B) the fact that such Fund is a direct or indirect security-holder of the applicable Essex Member and that such Essex Member owns securities of the Company, and, if applicable, the fact that 


  
 52 








 
such Fund invested in the Company alongside investment funds managed by Essex GP, (C) the number, type, and relative percentages of securities of the Company that are held directly or
indirectly by such Fund, (D) the total amount of such Fund’s direct or indirect investment in the Company, (E) the amount of distributions received directly or indirectly by such Fund from the Company, (F) the net asset value of
such Fund’s direct or indirect investment in the Company, (G) such ratios and performance information as calculated by such Fund Manager using the information in clauses (D) through (F) above, (H) with respect to any
distribution in-kind of securities, the name and issuer of such securities, the number of such securities distributed to such Fund and the fair market value at the time of distribution, and (I) such other information as may be required to be
disclosed by Applicable Law or GAAP standards or principles applicable to such Fund Manager or Fund; provided that, (1) with respect to the disclosure of any Confidential Information pursuant to Section 9.09(d)(i), such disclosure shall be
made on the condition that the Funds and the Fund Managers agree to keep any such Confidential Information confidential to the same extent as the Essex Members are required to keep the Confidential Information confidential pursuant to the terms
hereof; (2) with respect to the disclosure of any Confidential Information pursuant to Section 9.09(d)(ii), such disclosure shall be made on the condition that the recipient of such information be bound by confidentiality obligations that
are similar to those that are applicable to the Essex Members pursuant to this Agreement (“Similar Confidentiality Obligations”); (3) with respect to any disclosure made under Section 9.09(d)(ii)(I), such Essex Member
shall cause the Fund or Fund Manager with which it is affiliated to comply with the advance notice and other requirements set forth in Section 9.09(c)(iii)(A) through (C); and (4) each Essex Member shall remain liable with respect to any
breach of this Section 9.09 by such Essex Member, its respective Funds or Fund Managers and their respective direct or indirect equity holders (provided that, for purposes of determining whether any such breach has occurred, (x) except as
provided in clause (y) of this proviso, such direct or indirect equity holders shall be deemed to be bound by the provisions of this Section 9.09, and (y) in the case of the direct or indirect equity holders of any funds-of-funds
managed or advised by Pantheon or any of its Affiliates (each, a “Pantheon Fund”), such direct or indirect equity holders shall be deemed only to be bound by the terms of any Similar Confidentiality Obligations then applicable to
such direct or indirect equity holders). 
 (e) The obligation not to disclose Confidential Information shall not apply to any part of
such Confidential Information that (i) is or becomes patented, published, or otherwise part of the public domain other than by acts of a party in contravention of this Agreement; (ii) is disclosed to a party by a third party, unless such
Confidential Information was obtained by such third party directly or indirectly from a party hereto on a confidential basis; (iii) prior to disclosure under this Agreement, was already in the possession of the disclosing party, unless such
Confidential Information was obtained directly or indirectly from the other party hereto on a confidential basis; or (iv) is independently acquired or developed by a disclosing party other than by acts of a party in contravention of this
Agreement. 
 Section 9.10 Corporate Opportunities; Non-Solicitation. Except as provided with regard to the Essex Members in
Section 9.13: 
 (a) In no event shall any Member or any individual serving as a Manager be liable to the Company, any Subsidiary of the
Company or to any party hereto for breaches of fiduciary or other similar duties by virtue of the fact that such individual fails to bring a business opportunity to the attention of the Company or any Subsidiary of the Company or presents a business
opportunity to a Member or an Affiliate of a Member (rather than, or in addition to, presenting such opportunity to the Company). This Section 9.10 shall not apply to any Member who is an employee of the Company or any Subsidiary of the
Company. 

  
 53 








 (b) Without limiting the generality of the foregoing, the Members expressly acknowledge
and agree that (i) each Member and its Affiliates are permitted to have, and may presently or in the future have, investments or other business relationships, ventures, agreements or arrangements with, or ownership of, entities engaged in the
same or a similar business to the business conducted by the Company and its Subsidiaries, and in related businesses other than through the Company and its Subsidiaries (an “Other Business”), (ii) each Member or its Affiliates
have or may develop a strategic relationship with businesses that are or may be competitive with the Company and its Subsidiaries, (iii) no Member or its Affiliates (including any Managers designated by such Member) will be prohibited by virtue
of their investment in the Company and its Subsidiaries or their service on the Board of Managers from pursuing and engaging in any such activities, (iv) no Member or its Affiliates (including any Managers designated by such Member) will be
obligated to inform the Company of any such opportunity, relationship or investment, (v) the other Members will not acquire, be provided with an option or opportunity to acquire or be entitled to any interest or participation in any Other
Business as a result of the participation therein of a Member or its Affiliates (including any Managers designated by such Member), (vi) the Members expressly waive, to the fullest extent permitted by Applicable Law, any rights to assert any
claim that such involvement breaches any duty owed to any Member, or the Company or its Subsidiaries or to assert that such involvement constitutes a conflict of interest by such Persons with respect to the Company or its Subsidiaries and
(vii) nothing contained herein shall limit, prohibit or restrict any Member, any of its Affiliates or any current or former Manager designated by such Member from serving on the board of directors or other governing body or committee of any
Other Business. This Section 9.10(b) shall not apply to any Member who is an employee of the Company or any Subsidiary of the Company. 

(c) Prior to the 18-month anniversary of the date of this Agreement, each Member agrees that it shall use its reasonable best efforts to cause
the Company not to, directly or through any controlled Affiliate (and the Essex Members shall cause Essex and its managed investment funds and controlled Affiliates thereof not to), directly target, solicit or hire (including in any consulting
capacity) any salaried employee of S&N, the Essex Members, any Affiliate of S&N, or any controlled Affiliate of any of the Essex Members without the prior written approval of the Chief Executive Officer of S&N, in the case of any such
employee of S&N or any of its Affiliates, or any authorized person of Essex, in the case of any such employee of the Essex Members or any of their controlled Affiliates, in any case except for any such employee terminated by S&N, Essex or
any applicable Affiliate of S&N or Essex. 
 (d) Prior to the 18-month anniversary of the date of this Agreement, S&N agrees that it
and its Affiliates shall not, and, each of the Essex Members agrees that Essex and its managed investment funds and controlled Affiliates thereof shall not, hire (including in any consulting capacity) any employee of the Company or any of its
Subsidiaries without the prior written approval of the Chief Executive Officer of the Company, except for any employee terminated by the Company or any of its Subsidiaries. 

  
 54 








 (e) As used in this Section 9.10, “controlled” has the meaning set forth in the
definition of the term “Affiliate” in Section 1.01(a). 
 Section 9.11 Certain Matters Relating to an
Initial Public Offering. (a) If the Board of Managers approves an Initial Public Offering in accordance with the terms of this Agreement (including the provisions of Annex A), the Board of Managers shall, unless otherwise agreed by
the Investors, and subject to Section 9.11(e), cause the Company to effect a conversion to corporate or other limited liability form or other appropriate reorganization (whether by conversion to a subchapter C corporation, merger, consolidation
into a corporation, recapitalization or reorganization, sale of securities, formation of a new parent entity or otherwise) that is reasonably acceptable to the Investors, giving effect to the same voting and corporate governance provisions contained
herein (the “Corporate Conversion”, and the resulting entity with respect to which the Initial Public Offering is expected to be consummated, the “IPO Entity”). Each Member hereby consents to such Initial Public
Offering and Corporate Conversion and shall vote for (to the extent it has any voting rights) and raise no objections against such Initial Public Offering and Corporate Conversion, and each Member shall, at the request of the Board of Managers, take
all actions (including any actions required to pursuant to Section 9.11(e)) reasonably necessary or desirable to effect such Initial Public Offering and Corporate Conversion. 

(b) Pursuant to the Corporate Conversion, and subject to Section 9.11(e), all Units held by each Member immediately prior to the
Corporate Conversion shall automatically be converted (the “Automatic Conversion”) into newly issued equity interests of the IPO Entity representing such Member’s IPO Percentage of the total number of issued and outstanding
equity interests of the IPO Entity. Subject to the provisions of Annex G, all of the equity interests of the IPO Entity issued pursuant to the Corporate Conversion shall be (i) of a single class and have the same rights, powers, preferences,
qualifications, limitations and restrictions as all other such equity interests and (ii) duly and validly issued, fully paid and non-assessable and free of all Liens (except as may arise under the terms of this Agreement) and not subject to any
preemptive rights. “IPO Percentage” means, with respect to any Member, the percentage of the total distributions to the Members pursuant to Section 10.05 that such Member would have received if the Company were dissolved, its
affairs wound up and (A) all of the assets of the Company were sold for cash equal to the sum of the aggregate equity valuation of the Company indicated by the pricing of the Initial Public Offering and the amount of the Company’s
liabilities, (B) all of the Company’s liabilities were satisfied and (C) the net assets were immediately distributed to the Members in accordance with Section 10.05. 

(c) Subject to Section 9.11(b), prior to the consummation of an Initial Public Offering, the Members shall, and shall cause the relevant
publicly-traded entity to, enter into agreements containing rights and obligations of the parties that are substantially similar to those contained in this Agreement, other than the rights and obligations of this Agreement that expressly terminate
upon the consummation of the Initial Public Offering. If any of such agreements are inconsistent with the rules of the principal exchange on which the shares of the publicly-traded entity are listed, the terms of such agreements shall be modified to
the extent necessary to reflect such rules; provided that such agreements shall, as closely as possible, give effect to the provisions of this Section 9.11(c). 

  
 55 








 (d) If the Essex Members and their Permitted Transferees participate in an Initial Public
Offering permitted by this Agreement, S&N and its Permitted Transferees shall be permitted to participate in such Initial Public Offering in accordance with Section 9.11(b). Upon the consummation of the Initial Public Offering, the holders
of Units (or such common stock as the Units have been converted into) shall have registration rights substantially as set forth in Annex B hereto. 

(e) Notwithstanding anything to the contrary contained herein, at the election of any Essex Member, S&N Blocker (after S&N Blocker
becomes a Member) or any Permitted Transferee thereof, in connection with a Corporate Conversion and Automatic Conversion, the Company shall effect a merger, consolidation, recapitalization, reorganization or other transaction with such Investor
that is reasonably acceptable to such Investor and the effect of which is that the owners of the equity interests of such Investor receive equity interests of the IPO Entity representing such Investor’s IPO Percentage of the total number of
issued and outstanding equity interests of the IPO Entity; provided that the Company and such Investor shall use their respective reasonable best efforts to effect any such merger, consolidation, recapitalization, reorganization or other transaction
in a tax-efficient manner. Any Permitted Transferee that seeks to participate in a transaction of the nature described in this Section 9.11(e) shall not, prior to such transaction, (i) own any assets of any kind other than Units and
(ii) have any liabilities of any kind, including Indebtedness. 
 Section 9.12 Business Development
Meetings. The Company and S&N shall jointly constitute a business development committee (the “Business Development Committee”) for the purpose of discussing trends, technologies and developments with respect to the
business of the Company and its Subsidiaries, and such other matters as the members of the Business Development Committee determine to address from time to time, subject to any restrictions imposed by Applicable Law or any confidentiality or
non-disclosure provision (in either case to the extent relating to third party information) in any agreement to which the Company or S&N is a party and other reasonable safeguards to address conflicts of interests. The Company and S&N shall
mutually determine the members of the Business Development Committee (which shall include representatives of S&N and the Company), dates, times and locations (provided that the Business Development Committee will meet at
least two times per year), format, costs and content. 
 Section 9.13 Essex Duties. For so long as the Essex Members and
their Affiliates, in the aggregate, have the right to designate a majority of the Board of Managers of the Company, the Essex Members will use their reasonable best efforts to ensure that S&N and its Affiliates are afforded by the Company and
the Board of Managers all of the protections that would be available to them under Applicable Law as minority shareholders of a Delaware corporation. 

Section 9.14 Investor Duties. The Investors agree to use reasonable best efforts to direct the Board of Managers to ensure that at
all times the Company (a) adopts and enforces ethics and compliance policies and programs designed to comply with all Applicable Law and industry ethical codes and (b) safeguards the reputations of the Company and the Investors. 

Section 9.15 Orthobiologics Commitment. The Company shall undertake and satisfy the Orthobiologics Commitment, as set forth on
Annex D hereto. 

  
 56 








 Section 9.16 Compliance with Applicable Law. (a) The Company will at all times
comply, and shall cause each of its Subsidiaries to comply, with the requirements of Applicable Law, including (i) the Federal Health Care Program Anti-Kickback Statute, 42 U.S.C. § 1320a-7b(b), and any anti-kickback law of any U.S. state,
(ii) the Federal False Claims Act, 31 U.S.C. § 3729, and any false claim or fraud law of any U.S. state, (iii) the Federal civil monetary penalty statute, 42 U.S.C. § 1320a-7a(5), (iv) the U.S. Foreign Corrupt Practices Act
of 1977, 15 U.S.C. §§ 78dd-1, et seq., (v) the Federal Physician Self-Referral Law, 42 U.S.C. §§ 1395nn et seq., and any physician self-referral law of any U.S. state, and (vi) the Federal Food and Drug and Cosmetic
Act, including the provisions thereof relating to establishment registration, registration of clinical trials, investigational use, pre-market clearance, licensure, or application approval, good manufacturing practices, good laboratory practices,
good clinical practices, product listing, labeling, advertising and promotion, and recordkeeping and filing of reports. 
 (b) The
Company shall promptly notify the Investors upon receipt of any complaint, order, citation, notice or other written communication from any Person with respect to, or upon the Company’s obtaining knowledge of, the existence or alleged existence
of a significant violation by the Company or any of its Subsidiaries of any Applicable Law, including (i) any warning or untitled letter, report of inspection observations (including U.S. Food and Drug Administration (the
“FDA”) Form 483s), establishment inspection report, notice of violation, clinical hold or other documents from the FDA or any other Governmental Authority relating to the products of the Company’s business and alleging a lack
of compliance by the Company or any of its Subsidiaries with any Applicable Law or regulatory requirements in connection with the Company’s business or (ii) any written notice or other written communication from the FDA or any other
Governmental Authority which (A) enjoins production at any facility of the Company’s business or (B) enters or proposes to enter into a consent decree with, or permanent injunction of, the Company or any of its Subsidiaries relating
to the conduct of the Company’s business. 
 Section 9.17 Certain Members’ Assets and Liabilities. For so long
as any Essex Member or, after S&N Blocker becomes a Member, S&N Blocker owns any Units, such Member shall not own any other assets of any kind or incur, create, assume or permit to exist any liabilities or obligations of such Member of any
kind, including Indebtedness, and shall take no actions other those incidental to such Member’s ownership of the Units. 

Section 9.18 S&N Accounting Periods. Not later than the beginning of the last S&N Accounting Quarter of each Fiscal Year,
S&N shall notify the Company of the S&N Accounting Months and S&N Accounting Quarters for the following Fiscal Year. 

Section 9.19 Remedies Upon Breach. In the event of any breach of any obligation under this Agreement or any
Related Document by any Investor (the “Breaching Investor”), if and to the extent that any other Investor actually incurs or sustains any Damages arising out of, with respect to or by reason of such breach (the
“Non-Breaching Investor”), then (a) the Non-Breaching Investor is authorized, upon written notice to the Breaching Investor, to set off and apply any and all Indebtedness or other obligations at any time owing by the
Non-Breaching Investor (including pursuant to this Agreement or any Related Document) to or for the credit or the account of the Breaching Investor against any and all such Damages, and (b) the Non-Breaching Investor’s shall have, in
addition to any other recourse available to it against the  

  
 57 








 
Breaching Investor pursuant to this Agreement or any other Related Document or at law or equity, an express right to recourse against any and all assets of the Breaching Investor (including the
Units and any proceeds thereof or thereon held by the Breaching Investor) provided that any amounts recovered by the Non-Breaching Investor pursuant to this Section 9.19 shall be without duplication of any amounts actually recovered by the
Non-Breaching Investor pursuant to the other provisions of this Agreement or the Related Documents. 
 ARTICLE 10 

TERM, DISSOLUTION AND LIQUIDATION 

Section 10.01 Term. The term of the Company shall continue from the date hereof until its termination pursuant to
Section 10.02. 
 Section 10.02 Liquidating Events. The Company shall dissolve and commence winding up
prior to the expiration of the term upon the first to occur of any of the following events (each a “Liquidating Event”): 

(a) the unanimous vote of the Investors to dissolve, wind up and liquidate the Company; or 

(b) the entry of a decree of judicial dissolution pursuant to Section 18¬802 of Delaware Law. 

Section 10.03 Winding Up. Upon the occurrence of a Liquidating Event, the Company shall continue solely for the purposes of
winding up its affairs in an orderly manner, liquidating its assets, and satisfying or making reasonable provisions for the satisfaction of the claims of its creditors and Members, and no Member or the Board of Managers (or any member thereof) shall
take any action that is inconsistent with, or not necessary to or appropriate for, the winding up of the Company’s business and affairs; provided that all covenants contained in this Agreement and obligations provided for in this
Agreement shall continue to be fully binding upon the Members until such time as the property or the proceeds from the sale thereof has been distributed pursuant to this Article 10 and the Company has terminated. The Investors shall be responsible
for overseeing the winding up and dissolution of the Company. The Investors shall take full account of the Company’s properties, assets and liabilities, and the Company’s affairs shall be wound up in a prompt and orderly manner. 

Section 10.04 Distribution Upon Dissolution of the Company. In connection with a liquidation or dissolution of the Company, the
Company’s property, or the proceeds from the sale thereof, shall be applied and distributed in accordance with Section 18-804 of Delaware Law in the following order: 

(a) first, to (i) the satisfaction (whether by payment or by the making of reasonable provision for payment) of all of the
Company’s debts and liabilities to creditors that are not Members or Managers and (ii) the payment of all principal, interest or any other amounts that remain outstanding under the S&N Note; 

  
 58 








 (b) second, to the satisfaction (whether by payment or by the making of reasonable
provision for payment) of all of the Company’s debts and liabilities to creditors that are Members or Managers (other than as provided for under Section 10.04(a)(ii)); and 

(c) third, the balance, if any, to the Members as set forth in Section 10.05. 

Section 10.05 Liquidation or Dissolution. (a) Upon any liquidation or dissolution of the Company, distributions shall be made
to the Members as follows: 
 (i) first, (A) the former holders of Preferred Units previously Transferred
pursuant to a Preferred Transfer Event are entitled to be paid the Accrued Preferred Distribution with respect to each such Transferred Preferred Unit, and (B) the holders of the Preferred Units then outstanding are entitled to be paid the
aggregate accrued and unpaid Preferred Distribution (for the avoidance of doubt, relating to the current Fiscal Year and all prior Fiscal Years) with respect to each such Preferred Unit as of such time, in each case, before any distribution of
assets is made pursuant to any of the following subparagraphs of this Section 10.05(a); 
 (ii) second,
the holders of the Preferred Units then outstanding are entitled to be paid the Liquidation Preference with respect to each such Preferred Unit as of such time (for the avoidance of doubt, taking into account any reduction of such Liquidation
Preference in respect of distributions made pursuant to Section 10.05(a)(i)(B), as provided by Section 4(b) of Annex C), before any distribution of assets is made pursuant to any of the following subparagraphs of this Section 10.05(a);

 (iii) third, (A) the holders of the Common Units (other than the Converted Common Units) then outstanding
are entitled to be paid, with respect to each Common Unit (other than the Converted Common Units), the Unreturned Capital Amount with respect to each such Common Unit, (B) the holders of the OUS Units then outstanding are entitled to be paid,
with respect to each OUS Unit, the Unreturned Capital Amount with respect to each such OUS Unit, and (C) the holders of the Converted Common Units then outstanding are entitled to be paid, with respect to each Converted Common Unit, the
Liquidation Preference with respect to the Preferred Unit that was converted into such Converted Common Unit pursuant to Section 3 of Annex C (for the avoidance of doubt, taking into account any increase to such Liquidation Preference
pursuant to the proviso set forth in the last sentence of Section 4(a) of Annex C), minus the Accrued Preferred Distribution with respect to such Preferred Unit, in each case, before any distribution of assets is made pursuant to the
following subparagraphs of this Section 10.05(a); 
 (iv) fourth, the holder of the EPR Unit is entitled to be
paid, with respect to the EPR Unit, the EPR Entitlement (if any) payable in accordance with Section 1 of Annex G, before any distribution of assets is made pursuant to the following subparagraph of this Section 10.05(a); and 

  
 59 








 (v) fifth: 

(A) the holders of any vested Profits Interest Units of any Class of Profits Interest Units are entitled to be paid, with
respect to each such Profits Interest Unit held by such holders, the Class Entitlement per Unit, if any, of such Class of Profits Interest Units; provided that in no event shall the sum of (1) the aggregate amount of any distributions
pursuant to this Section 10.05(a)(v)(A) and (2) the aggregate amount of any payments to the holders of any Phantom Profits Interest Units or any Other Management Equity Awards exceed 10% of the amount available for distribution to the
Members pursuant to this Section 10.05(a)(v) (such amount determined, solely for this purpose, as if there were no Phantom Profits Interest Units or Other Management Equity Awards), and any such distributions or payments shall be adjusted as
determined by the Board of Managers pro rata in accordance with the number of vested Profits Interest Units, Phantom Profits Interest Units and any Other Management Equity Awards outstanding at such time to the extent necessary in order to avoid
aggregate distributions or payments that would exceed the foregoing cap; and provided, further, that, for the avoidance of doubt, the holders of any unvested Profits Interest Units of any Class of Profits Interest Units are not entitled to be
paid any amount at all pursuant to this Section 10.05(a)(v)(A); 
 (B) the holders of the Preferred Units and the Converted
Common Units are entitled to be paid, with respect to each such Unit held by such holders, the pro rata share per Unit of the Preferred Percentage of the remaining amount available for distribution to the Members; 

(C) (1) the holders of the OUS Units are entitled to be paid, with respect to each such OUS Unit held by such holders,
the pro rata share per Unit of the lesser of (I) the excess of (x) the cumulative amount of net profit previously allocated to such holders pursuant to Section 4.06 that is attributable to U.S. Gain over (y) the aggregate
distributions made with respect to such OUS Units attributable to U.S. Gain and (II) an amount equal to the product of (x) the Common/OUS Percentage multiplied by (y) the U.S. Gain, and (2) the holders of the Common Units (other than
the Converted Common Units) are entitled to be paid, with respect to each such Common Unit held by such holders, the pro rata share per Unit of the amount equal to (I) the product of (x) the Common/OUS Percentage multiplied by (y) the
U.S. Gain, minus (II) the amount paid to the holders of the OUS Units pursuant to Section 10.05(a)(v)(C)(1); and 

(D) the holders of the OUS Units are entitled to be paid, with respect to each such Unit held by such holders, the
pro rata share per Unit of the product of (1) the Common/OUS Percentage multiplied by (2) the OUS Gain. 
 (b)
If, upon any liquidation or dissolution of the Company, the available assets of the Company are insufficient to pay the full amount of the liquidating distributions provided for in Section 10.05(a)(i), then the holders of the Preferred Units
(or, in the case of Section 10.05(a)(i)(A), the former holders of the Preferred Units) shall share ratably in the total amount available for distribution pursuant to Section 10.05(a)(i) in proportion to the full liquidating distributions
to which they would have been respectively entitled had the available assets of the Company been sufficient to pay the full amount of the liquidating distributions provided for in Section 10.05(a)(i). 

  
 60 








 (c) If, upon any liquidation or dissolution of the Company, the available assets of the Company
are sufficient to pay the full amount of the liquidating distributions provided for in Section 10.05(a)(i), but insufficient to pay the full amount of the liquidating distributions provided for in Section 10.05(a)(ii), then the holders of
the Preferred Units shall share ratably in the total amount available for distribution pursuant to Section 10.05(a)(ii) in proportion to the full liquidating distributions to which they would have been respectively entitled had the available
assets of the Company been sufficient to pay the full amount of the liquidating distributions provided for in Section 10.05(a)(ii). 

(d) If, upon any liquidation or dissolution of the Company, the available assets of the Company are sufficient to pay the full amount of the
liquidating distributions provided for in Sections 10.05(a)(i) and 10.05(a)(ii), but insufficient to pay the full amount of the liquidating distributions provided for in Section 10.05(a)(iii), then the holders of the Common Units (including,
for the avoidance of doubt, the Converted Common Units) and the OUS Units shall share ratably in the total amount available for distribution pursuant to Section 10.05(a)(iii) in proportion to the full liquidating distributions to which they
would have been respectively entitled had the available assets of the Company been sufficient to pay the full amount of the liquidation distributions provided for in Section 10.05(a)(iii). 

Section 10.06 Company Sale. Any Company Sale, and any other consolidation or merger of the Company or any of its Subsidiaries with
or into any Person or Persons, Transfer of all or substantially all of the assets of the Company and its Subsidiaries to any Person or Persons or Transfer of all of the Units then outstanding (whether pursuant to any Drag-Along Sale, Tag-Along Sale
or otherwise) to any Person or Persons, shall be deemed to constitute a liquidation, dissolution and winding up of the Company solely for purposes of (a) in the case of a Company Sale where the proceeds of such Company Sale are payable to the
Company, distributing the proceeds thereof and (b) in the case of a Company Sale where the proceeds of such Company Sale are payable to the Members and/or the owners of the equity interests of the Members, allocating the proceeds thereof among
such Persons, and such proceeds shall be distributed or allocated, as the case may be, in accordance with Section 10.05. For the avoidance of doubt, this Section 10.06 shall apply to any of the transactions referred to in the immediately
preceding sentence without regard to whether the proceeds of such transaction are payable to the Company or the Members (or, in the case of a Member Entity Transfer, the holders of the equity interests of the applicable Member) pursuant to the terms
of such transaction, and the Company and the Members hereby agree to take all action necessary to effect the distribution or allocation of proceeds of any such transaction as provided by this Section 10.06. 

Section 10.07 Rights of Members; Resignation. (a) Except as otherwise provided in this Agreement, each Member shall look
solely to the property of the Company for the return of its Capital Contributions, and, except in respect of the Company’s Indebtedness or obligations to a Member, shall have no right or power to demand or receive property other than cash from
the Company. 
 (b) No Member shall resign from the Company (in its capacity as a Member) prior to the dissolution and winding up of the
Company in accordance with this Agreement. 

  
 61 








 ARTICLE 11 

MISCELLANEOUS 

Section 11.01 Notices. All notices, requests and other communications to any party or to the Company shall be
in writing (including telecopy or similar writing and electronic mail (“e-mail”) transmission, so long as a receipt of such e-mail is requested and received) and shall be given, 

if to the Company to: 
 Bioventus
LLC 
 4271 Emperor Parkway 

Durham, NC 27703 
 Attention: Mark
A. Augusti 
 Facsimile No.: 919-474-6893 

with a copy (which shall not constitute notice) to: 

Bioventus LLC 
 4271 Emperor
Parkway 
 Durham, NC 27703 

Attention: Jeanne M. Forneris 

Facsimile No.: 919-474-6893 
 if
to any Essex Member to: 
 Essex Woodlands 

280 Park Avenue, 27th Floor East 

New York, New York 10017 

Attention: Scott Barry 
 Facsimile
No.: (212) 922-0551 
 E-mail: sbarry@ewhv.com 

with a copy (which shall not constitute notice) to: 

Reed Smith LLP 
 599 Lexington
Avenue, 22nd Floor 
 New York, New York 10022 

Attention: Patrick F. Rice, Esq. 

Facsimile No.: (212) 521-5450 

E-mail: price@reedsmith.com 
 if
to S&N or S&N Blocker, to: 
 Smith & Nephew, Inc. 

7135 Goodlett Farms 
 Cordova, TN
38106 

  
 62 








 Attention: Chief Legal Officer 

Facsimile No.: 901-396-7824 

E-mail: company.secretary@smith-nephew.com 

with a copy (which shall not constitute notice) to: 

Davis Polk & Wardwell LLP 

450 Lexington Avenue 
 New York,
New York 10017 
 Attention: Ajay B. Lele 

Facsimile No.: 212-701-5800 
 if
to any other Member, to: 
 The address specified in the Company’s records 

or to such other address or telecopier number as such party or the Company may hereafter specify for the purpose by notice to the other parties and the
Company. Each such notice, request or other communication shall be effective when delivered at the address specified in this Section 11.01 during regular business hours. 

Section 11.02 Representations and Warranties. (a) Each Member hereby acknowledges that the Units have not been issued by the
Company pursuant to a registration statement under the Securities Act. Neither the Company, nor any other Person has any obligation or intention to effect the registration of the Units for sale, transfer or disposition by the Members under the
Securities Act or Applicable Law, or to take any action that would make available any exemption from the registration requirements of the Securities Act or Applicable Law. Members must therefore hold such Units indefinitely unless a subsequent
registration or exemption therefrom is available and is obtained. No federal or state agency has reviewed the issuance of the Units pursuant hereto or approved or disapproved the Units to be issued pursuant hereto for investment or any other
purpose. 
 (b) Each Member acknowledges that (i) it is acquiring the Units for its own account, as principal and not on behalf of any
other party or parties and for investment and not with a view to the resale or distribution of all or any part of such Units and (ii) it has been afforded the opportunity to ask questions of, and to obtain any information from, the Company and
the Board of Managers as it deems necessary to determine the suitability and advisability of the purchase of the Units pursuant hereto and the merits and risk of entering into this Agreement. 

Section 11.03 Amendments; No Waivers. (a) Any provision of this Agreement may be amended or waived if, and only if, such
amendment or waiver is in writing and signed, in the case of an amendment, by S&N, S&N Blocker (after S&N Blocker becomes a Member), each of the Essex Members and the Company, or in the case of a waiver, by the Member against whom the
waiver is to be effective; provided that any amendment that adversely and disproportionately affects any Member shall require the approval of such Member. 

  
 63 








 (b) No failure or delay by any party in exercising any right, power or privilege hereunder shall
operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. No waiver of any breach of this Agreement shall be held to constitute
a waiver of any other or subsequent breach. The rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by law. 

Section 11.04 Expenses. Except as provided in the Expense Side Letter, all costs and expenses incurred by the parties in
connection with this Agreement shall be paid by the party incurring such costs or expenses. 
 Section 11.05 Public
Announcements. No party to this Agreement shall issue any news release or make any public announcement, written or oral, relating to this Agreement or any Related Document or the existence of any arrangement between the parties, without the
prior written consent of the party whether named in such news release or other public announcement or not, except where such news release or other public announcement is compelled by judicial or administrative process or by other requirements of law
or by the rules of any securities exchange or national securities quotative system pursuant to a listing agreement therewith; provided that in such event, the party issuing same shall still use reasonable efforts to consult with the other party,
whether named in such news release or public announcement or not, a reasonable time prior to its release to allow the other party to comment thereon and, after its release, shall provide the other party with a copy thereof 

Section 11.06 Successors and Assigns. The provisions of this Agreement shall be binding upon and inure to the benefit of the
Members and their respective successors and permitted assigns. Notwithstanding the foregoing, neither this Agreement nor any right, remedy, obligation or liability arising hereunder or by reason hereof shall be assignable other than in connection
with a Transfer permitted pursuant to Article 8. This Agreement is for the sole benefit of the Members and the Company, and, except as otherwise contemplated herein, nothing herein expressed or implied shall give or be construed to give any Person,
other than the Members and the Company, any legal or equitable rights hereunder. With respect to the Profits Interest Members, any benefit conferred on any other Member(s) to the exclusion of the Profits Interest Members is for the sole benefit of
such other Member(s) and nothing herein shall give or be construed to give any Profits Interest Members any legal or equitable rights hereunder with respect to such benefit. 

Section 11.07 Headings. Headings are for ease of reference only and shall not form a part of this Agreement. 

Section 11.08 Governing Law. This Agreement shall be construed in accordance with and governed by the law of the State of Delaware
without giving effect to the principles of conflicts of laws thereof 
 Section 11.09 Jurisdiction. Any suit, action or
proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement may be brought against any of the parties in any federal court located in the State of Delaware or any Delaware state court,
and each of the parties hereby consents to the exclusive jurisdiction of such 

  
 64 








 
court (and of the appropriate appellate courts) in any such suit, action or proceeding and waives any objection to venue laid therein. Process in any such suit, action or proceeding may be served
on any party anywhere in the world, whether within or without the jurisdiction of any such court. Without limiting the foregoing, the parties agree that service of process upon such party at the address referred to in Section 11.01, together
with written notice of such service to such party, shall be deemed effective service of process upon such party. 
 Section 11.10
WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. 

Section 11.11 Entire Agreement. This Agreement (including the Annexes constituting a part of this Agreement; all references to
this Agreement shall be deemed to include each Annex to this Agreement) and any other writing signed by authorized representatives of each of the parties after the date hereof that specifically references this Agreement, constitute the entire
agreement among the parties with respect to the subject matter hereof and supersede all prior agreements, understandings and negotiations, both written and oral between the parties with respect to the subject matter hereof. Except as expressly
provided herein, this Agreement is not intended to confer upon any Person other than the parties hereto any rights or remedies hereunder. 

Section 11.12 Counterparts; Effectiveness. This Agreement may be signed in any number of counterparts, each of which shall be
deemed an original. This Agreement shall become effective when each party shall have received a counterpart hereof signed by each of the other parties. An executed copy or counterpart hereof delivered by facsimile shall be deemed an original
instrument. 
 Section 11.13 Severability. If any provision of this Agreement or the application thereof to any Person or
circumstance shall be invalid or unenforceable to any extent, the remainder of this Agreement and the application of such provisions to other Persons or circumstances shall not be affected thereby and shall be enforced to the greatest extent
permitted by law. 
 Section 11.14 Further Assurances. The Members shall execute and deliver such further instruments and do
such further acts and things as may be required to carry out the intent and purpose of this Agreement. 
 Section 11.15 Specific
Performance. The parties hereto agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with the terms hereof and that the parties shall be entitled to an injunction or injunctions to prevent
breaches of this Agreement or to enforce specifically the performance of the terms and provisions hereof in any federal or state court located in the State of Delaware, in addition to any other remedy to which they are entitled at law or in equity.

 [Remainder of page intentionally left blank] 

  
 65 








 IN WITNESS WHEREOF, the parties hereto have entered into this Agreement or have caused this
Agreement to be duly executed by their respective authorized officers, in each case as of the day and year first above written. 
  

			
	SMITH & NEPHEW, INC.
		
	By:	 	/s/ R. Gordon Howe
		 	  

		 	Name: R. Gordon Howe
		 	 Title: Senior Vice President

          Global Planning & Development



 [Signature Page to LLC Agreement] 







 
			
	BIOVENTUS LLC
		
	By:	 	/s/ Mark A. Augusti
		 	  

		 	Name: Mark A. Augusti
		 	Title: Chief Executive Officer


 [Signature Page to LLC Agreement] 







 
			
	 BELUGA I, INC.
  

By: BELUGA BV, LLC, as its Attorney-in-Fact
  

By: ESSEX WOODLANDS HEALTH
 VENTURES VIII, LLC, its
manager

		
	By:	 	/s/ Martin P. Sutter
		 	  

		 	Name: Martin P. Sutter
		 	Title: Manager
	
	 BELUGA II, INC.
  

By: BELUGA BV, LLC, as its Attorney-in-Fact
  

By: ESSEX WOODLANDS HEALTH
 VENTURES VIII, LLC, its
manager

		
	By:	 	/s/ Martin P. Sutter
		 	  

		 	Name: Martin P. Sutter
		 	Title: Manager
	
	 BELUGA III, INC.
  

By: BELUGA BV, LLC, as its Attorney-in-Fact
  

By: ESSEX WOODLANDS HEALTH
 VENTURES VIII, LLC, its
manager

		
	By:	 	/s/ Martin P. Sutter
		 	  

		 	Name: Martin P. Sutter
		 	Title: Manager


 [Signature Page to LLC Agreement] 







 
			
	 BELUGA IV, INC.
  

By: BELUGA BV, LLC, as its Attorney-in-Fact
  

By: ESSEX WOODLANDS HEALTH
 VENTURES VIII, LLC, its
manager

		
	By:	 	/s/ Martin P. Sutter
		 	  

		 	Name: Martin P. Sutter
		 	Title: Manager
	
	 BELUGA V, INC.
  

By: BELUGA BV, LLC, as its Attorney-in-Fact
  

By: ESSEX WOODLANDS HEALTH
 VENTURES VIII, LLC, its
manager

		
	By:	 	/s/ Martin P. Sutter
		 	  

		 	Name: Martin P. Sutter
		 	Title: Manager
	
	 BELUGA VI, INC.
  

By: BELUGA BV, LLC, as its Attorney-in-Fact
  

By: ESSEX WOODLANDS HEALTH
 VENTURES VIII, LLC, its
manager

		
	By:	 	/s/ Martin P. Sutter
		 	  

		 	Name: Martin P. Sutter
		 	Title: Manager


 [Signature Page to LLC Agreement]